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RECOMBINANT ANTIGEN AND MONOCLONAL ANTIBODY 
PRODUCTION FOR KATANIN p60 
SUMMARY 
Katanin, one of the proteins that severs microtubules, is a heterodimer composed of 
two subunits termed p60 and p80. The p60 subunit is an enzyme that hydrolyzes 
ATP to break the lattice of the microtubule where the p80 subunit regulates the 
activity of p60 and localizes it to the centrosomes. Severing activity of katanin p60 
has critical roles in mitotic and meiotic cell divisions and in axonal growth and 
differentiation in postmitotic neurons. Katanin may also function in various aspects 
of neuronal morphology such as the length, number and branching patterns of 
neuritis. Although, katanin has been extensively studied, interacting proteins of 
katanin p60 are not well understood. Monospecific antibodies could be helpful to 
monitor cellular katanin and find out its interacting proteins. Therefore, in this study, 
it is aimed to express specific recombinant katanin p60 protein and produce 
monoclonal antibodies against this protein for further use in immunocytochemistry, 
immunoprecipitation and western blot techniques.  
For this purpose, an amino acid sequence was selected from full katanin p60 protein 
considering specificity, solubility and inclusion of antigenic determinants of the 
protein and expressed efficiently. 6-8 weeks old Balb/c mice were then immunized 
with purified recombinant katanin p60 protein. Fusion study was carried out by using 
hybridoma technology with a mouse having high immune response. The main source 
of antibody producer B lymphocytes, spleen and lymph node cells, were fused with 
myeloma cells in the presence of polyethylenglycol. ELISA (Enzyme Link Immuno 
Sorbent Assay) cross reactivity test results showed that one hybrid clone was 
obtained among 295 hybrid clone as a candidate for producing a specific monoclonal 
antibody against katanin p60. Further ELISA tests showed that the monoclonal 
antibody subtype was not IgG but it could be IgA or IgM subtypes. Later, exact 
subtype of the monoclonal antibody was determined as IgM using mouse monoclonal 
antibody isotyping kit. 
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KATANĐN P60 ĐÇĐN REKOMBĐNANT ANTĐJEN VE MONOKLONAL 
ANTĐKOR ÜRETĐMĐ 
ÖZET 
Mikrotübülleri kesen proteinlerden biri olan katanin, p60 ve p80 olarak tanımlanan 
iki alt üniteden oluşan bir heterodimerdir. p60 alt ünitesi mikrotübülün kafesini 
kırmak için ATP yi hidrolizleyen bir enzim iken, p80 alt ünitesi p60’ın aktivitesini 
düzenler ve sentrozoma lokalize eder. p60’ın kesim aktivitesi mitotik, miyotik hücre 
bölünmesinde ve postmitotik nöronların aksonal büyüme ve farklılaşmasında kritik 
rollere sahiptir. Katanin ayrıca, nöritlerin uzunluk, sayı ve dallanma modelleri gibi 
nöronal morfolojinin çeşitli durumlarında fonksiyon gösterebilmektedir. Katanin 
proteini şu ana kadar çok fazla çalışılmış olmasına rağmen, etkileştiği proteinler çok 
iyi anlaşılamamıştır. Monospesifik antikorlar, hücresel kataninin görüntülenmesi ve 
etkileşen proteinlerinin belirlenmesinde yardımcı olabilir. Dolayısıyla bu çalışmada, 
spesifik bir rekombinant katanin p60’ ın ekspresyonunun yapılması ve  
immunositokimya, immunopresipitasyon ve western emdirimi tekniklerinde ileride 
kullanılmak üzere, bu proteine karşı monoklonal antikorlar üretilmesi 
amaçlanmaktatır. 
Bu amaçla, tam katanin p60 proteininden özellikliği, çözünebilirliği ve antijenik 
determinant içeriği göz önünde bulundurularak bir amino asit dizisi seçildi ve verimli 
bir anlatım sisteminde anlatımı yapıldı. Sonra, 6-8 haftalık Balb/c türü fareler 
saflaştırılmış rekombinant katanin p60 proteini ile bağışıklandırıldı. Yüksek bağışık 
cevabı olan fare üzerinde hibridoma teknolojisi kullanılarak füzyon çalışmaları 
gerçekleştirildi. Antikor üreten B lenfositlerin ana kaynağı olan dalak ve lenf 
düğümü hücreleri, polietilenglikol varlığında miyelom hücreleri ile birleştirildi. 
ELISA (Enzim Bağlantılı Immuno Sorbent Ölçümü) kross reaktivite test sonuçları, 
295 melez klon arasından katanin p60’ a karşı spesifik monoklonal antikor üretmeye 
aday bir melez klon, elde edildiğini göstermiştir. Daha sonraki ELISA testleri, bu 
monoklonal antikorun alt tipinin IgG olmadığı ancak IgA ya da IgM alt tipi 
olabileceğini göstermiştir. Bununla beraber, monoklonal antikorun kesin alt tipi fare 
monoklonal antikor izotipleme kiti ile IgM olarak belirlenmiştir. 
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1. INTRODUCTION 
1.1 Cytoskeleton 
Cells are supported by a network of protein fibers extending throughout the 
cytoplasm called the cytoskeleton. This dynamic structure maintains cells’ shape, 
enables several types of cell motility, and plays important roles in both intracellular 
transport (the movement of vesicles and organelles) and cellular division. The 
cytoskeleton is composed of three main cytoplasmic filament networks: 
microtubules, microfilaments, and intermediate filaments (Campbell and Reece, 
2005).  
 
Figure 1.1: The major structural components of cytoskeleton. Centrosomes (magenta), microtubules 
(green), chromosomes (blue) and keratin filaments (red) are shown in the mitotic spindle 
that is central to the process  of cell division (Dunn, 2000). 
Briefly, intermediate filaments provide mechanical strength and resistance to shear 
stress. Microtubules determine the positions of membrane-enclosed organelles and 
direct intracellular transport and are involved in cell division in the course of drawing 
chromosomes to the poles. Microfilaments (composed of actin filaments) determine 
the shape of the cell’s surface and are necessary for whole-cell locomotion (Alberts 
et al., 2002). 
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1.2 Microtubules 
Microtubules shape and support the cell and also serve as tracks along which 
organelles equipped with motor proteins can move. For example, microtubules guide 
secretory vesicles from the Golgi apparatus to the plasma membrane by “dynein 
walking”. Moreover, microtubules have an essential role in the separation of 
chromosomes during cell division (Campbell and Reece, 2005).  
1.2.1 Microtubule structure and organization 
Microtubules are ~25 nm diameter hollow tubes with walls made from α- tubulin and 
β- tubulin heterodimers stacked head to tail at 8 nm intervals to form 
“protofilaments” that run lengthwise along the wall (Fig 1.2). Microtubule 
architecture in living cells depends on the number of protofilaments, usually 13, but a 
very wide range is possible (Meurer-Grob et al., 2001). α- and β- tubulin monomers 
are proteins of about 450 amino acids each and are about 50 % identical at the amino 
acid level. Each monomer has a molecular mass of about 50,000 Da and there are 
two GTP binding sites on tubulin, a hydrolyzable site (exchangeable site) on the β- 
subunit and a non-hydrolyzable site on the α- subunit (Valiron et al.,2001; Meurer-
Grob et al.,2001). 
 
Figure 1.2: Microtubule structure (Valiron et al., 2001). 
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The structure of microtubule is organized in a polar manner such that the α-tubulin 
subunit is exposed at the minus end, while the β-tubulin subunit is exposed at the 
plus end (Risinger et al., 2009). 
One member of the tubulin superfamily is γ- tubulin; it is localized to microtubule 
organizing centers, such as centrosomes and is also found in the cytoplasm as a part 
of a large complex called γ-tubulin ring complex (γ-TuRC) (Job et al., 2003),   in 
which the γ-tubulin subunit serves as a template to initiate the polymerization of the 
α/ β- tubulin into a microtubule (Wiese and Zheng, 2006).  
A full 55 % of microtubules formed in the presence of γ-TuRC have one complex at 
their minus end and very few have γ-TuRCs in their middles or at the plus ends (Job 
et al., 2003). Therefore, the faster polymerizing end was termed the ‘plus’ end and 
the more slowly polymerizing end the ‘minus’ end.  Microtubules with free minus 
ends may be generated by release from a microtubule organizing center, cytoplasmic 
assembly, or breakage/ severing of existing microtubules (Fig. 1.3).      
 
Figure 1.3: Microtubule nucleation from centrosome, adapted from Dammermann et al. (2003). 
In nerve axons, the microtubules are arranged longitudinally with the plus end 
pointing away from the cell body, whereas in epithelial cells microtubules are 
organized with the plus end pointing toward the basement membrane. In most other 
cells, such as fibroblasts and macrophages, microtubules radiate from the cell center 
with the plus ends pointing toward the periphery (Hirokawa, 1998). 
1.2.2 Microtubule dynamics 
Microtubule dynamics are important for rapid cellular restructuring of the 
cytoskeleton, as well as for mediating the delivery of cellular cargos. For example, 
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during mitosis, dynamic MTs mediate the alignment of sister chromatids at the 
spindle equator during metaphase, and ultimately segregate the sister chromatids into 
the nascent daughter cells during anaphase (Inoue and Salmon, 1995). 
Microtubule polymerization is a complex process involving a cooperative assembly 
of α β tubulin heterodimers followed by GTP hydrolysis. As mentioned before, the α- 
subunit binds to GTP in an irreversible manner, while the GTP bound to β- tubulin is 
exchangeable and it is hydrolyzed during polymerization. Thus, the majority of β-
tubulin in the microtubule fiber is in the GDP-bound form and ‘‘capped” with GTP-
bound β tubulin at the plus end. This leads to its elongation and formation of the 
protofilament (Singh et al., 2008). 
When the GTP on β-tubulin molecule is hydrolyzed to GDP before another GTP-
bound β-tubulin is added, the exposed GDP-β-tubulin leads to a conformational 
change that results in rapid depolymerization of the microtubule in an event known 
as microtubule catastrophe while a transition from a shortening phase to a growing 
phase is termed as a rescue. The relatively rapid lengthening and shortening at the 
microtubule plus end is referred to as dynamic instability (Risinger et al., 2008; 
Singh et al., 2008) (Fig 1.4). 
 
Figure 1.4: Dynamic instability (Wiese and Zheng, 2006). 
Microtubule assembly and activity in the cells is considered to be precisely regulated 
by several proteins, called as microtubule associated proteins (MAPs) (Singh et al., 
2008). MAPs bind to the tubulin subunits that make up microtubules to direct their 
stability (Dehmelt and Halpain, 2005). MAPs were shown to stimulate microtubule 
assembly. However, MAPs are not restricted only to stabilize microtubules, some 
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can mediate the interaction of microtubules with other cellular components and some 
can destabilize or severe microtubules. MAPs can act on a microtubule directly, or 
they can restrict access to the microtubules to other MAPs or motor proteins by 
binding to microtubule (Baas and Qiang, 2005). A broad range of MAPs functions 
suggests that it is the coordinated action of MAPs that leads to the proper 
microtubule functioning (Maiato et al., 2004). Coordination faults may lead to 
diseases, e.g. Alzheimer’s (Baas and Qiang, 2005). 
Both structure and the polarity of the microtubule serve as a rail on which 
microtubule associated motor proteins, such as kinesin and dynein superfamily 
proteins, convey their cargoes (Hirokawa, 1998). Transport occurs along 
microtubules when the appropriate motor binds to a cargo through its ‘tail’ and 
simultaneously binds to the rail through one of its ‘heads’. The motor then moves 
along the rail in such a “walking” manner by using repeated cycles of coordinated 
binding and unbinding of its two heads, powered by energy derived from hydrolysis 
of ATP (Mallik and Gross, 2004). Impaired transport may play a role for example; 
impaired axonal transport of molecules by motor proteins was linked to the 
pathogenesis of Alzheimer’s disease (Stokin and Goldstein, 2006). 
1.3 Microtubule Severing 
Since dynamic instability is not sufficient to explain the entirety of microtubule 
behaviors observed in cells, there exists an additional pathway by which microtubule 
dynamics can be affected: microtubules can be broken or severed along their length 
(Baas et al., 2005; Quarmby, 2000). 
In mitotic cells, microtubule severing on the spindles is thought to contribute to 
spindle reorganization (Ahmad and Baas, 1995). For example, severing near the 
centrosome could provide the opportunity for minus-end-directed flux of the mitotic 
spindle microtubules during metaphase (Mitchison, 1989). Microtubule severing may 
also play roles in the specific activities on differentiated cells such as myocytes, 
epithelial cells and neurons (Quarmby and Lohret, 1999; Quarmby, 2000). In 
postmitotic neurons, microtubules are not used for the formation of a mitotic spindle 
but rather for the elongation of axons (Karabay et al., 2004). Important events for 
axonal differentiation such as elongation, branching, navigation, retraction, are 
accomplished by changes in the configuration and behavior of microtubules (Baas 
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and Buster, 2004). Microtubule severing in neurons is introduced by suggesting that 
all neuronal microtubules are nucleated at the centrosome and then relocated to 
populate locales such as axons and dendtires (Baas et al., 2005). 
.  
Figure 1.5: Microtubule array of the postmitotic neuron (Baas, 1999). 
Microtubule is released from minus end or severed by a severing enzyme and 
transport of these non-centrosomal microtubules is conveyed by motor proteins 
(Keating et al, 1997). 
1.4 Katanin 
Microtubule severing activity is first identified in mitotic extracts of Xenopus laevis 
eggs (Vale, 1991). Microtubule severing protein is later characterized initially by 
purification from sea urchin eggs and named katanin that is originated the Japanese 
word for samurai sword “katana”. This heterodimeric protein is a microtubule-
stimulated ATPase and that ATP hydrolysis is performed to disassemble stable 
microtubules (McNally and Vale, 1993).  
1.4.1 AAA superfamily ATPases 
Katanin is a member of the conserved AAA family of ATPases (Confalonieri and 
Duguet, 1995). AAA ATPases (ATPases Associated with various cellular Activities) 
play important roles in numerous cellular activities including proteolysis, protein 
folding, membrane trafficking, cytoskeletal regulation, organelle biogenesis, DNA 
replication and intracellular motility (Vale, 2000). All members of the AAA family 
are Mg2+dependent ATPases. The AAA motif is defined by a conserved sequence of 
230 to 250 amino acids that includes the Walker signature sequences of P-loop 
ATPases and other regions of similarity unique to AAA proteins. The classical AAA 
proteins are easily recognized by their strong sequence conservation in this domain 
(about 30% identity) (Patel and Latterich, 1998; Vale, 2000).  
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AAA proteins function as an oligomeric ring complex (Hartman et al., 1998), 
although according to Patel and Latterich (1998) they are also monomers. Katanin 
exists in equilibrium between monomers and oligomers. In this case of the katanin, 
the oligometric state has been shown to be hexameric ring where ATP binding 
induces conformational changes at the interface region which increase interactions 
between AAA protein and its target (Hartman and Vale, 1999).  
1.4.2 Katanin function and regulation 
The AAA enzyme katanin breaks microtubules along the length of a microtubule by 
removing tubulin dimers from the wall of the microtubule. Released tubulin dimers 
are able to repolymerize again, so they are not proteolyzed or modified by katanin 
(McNally and Vale, 1993). Microtubules act as a scaffold upon which katanin 
oligomerizes after it has exchanged its ADP for ATP. As a consequence of ATP 
hydrolysis and subsequent phosphate release, the katanin undergoes a conformational 
change leading to destabilization of tubulin-tubulin contacts. The ADP- bound 
katanin has lower affinity both for other katanin molecules and for tubulin; this leads 
to the dissolution of the complex and recycling of the katanin (Hartman and Vale, 
1999; Quarmby, 2000) (see Fig 1.6). This model suggests several possible points of 
regulation: a nucleotide-exchange factor could regulate loading of p60 with ATP; 
accessibility to microtubules could be regulated by removal of protective MAPs; 
oligomerization sites on p60 could be reversibly masked by regulatory factors; and 
other factors could stimulate or inhibit ATP hydrolysis and severing (Quarmby, 
2000). However, the exact mechanism of microtubule severing is still unknown.  
 
Figure 1.6: Microtubule severing by katanin (swords) (Quarmby 2000). 
Katanin display an unusual microtubule- stimulated ATPase reaction in which the 
activity peaks at a microtubule concentration of 2 to 10 µM tubulin dimers then, 
decreases as the microtubule concentration is further increased (Hartman and Vale, 
1999). 
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Early studies on katanin earmarked it as a protein that severs microtubules during 
mitosis. Katanin activity, assessed by the degree to which microtubules were 
severed, was found to be higher in mitotic extracts than interphase extracts (Vale, 
1991). Then, katanin was found to be highly concentrated at centrosomes through the 
cell division (McNally et al., 1996). Katanin severs microtubules from their γ-TuRC 
caps and allows minus end depolymerization during mitosis (Buster et al., 2002). 
These findings support the hypothesis that katanin mediates the disassembly of 
microtubule minus end during poleward flux (McNally et al., 1996, Quarmby 2000; 
Buster et al., 2002). However, katanin’s role in flux or chromosome motility has not 
been previously demonstrated. In addition, Drosophila melanogaster katanin 
orthologues appear to function primarily on anaphase chromosomes, where it 
stimulates microtubule plus-end depolymerization and Pacman-based chromatid 
motility (Zhang et al., 2007). In Caenorhabditis elegans, katanin is involved in 
meiosis, allowing the late meiotic spindle shortening (McNally et al., 2006) and 
increasing the MT density during spindle assembly in acentrosomal female cells 
from a relatively inefficient chromatin-based MT nucleation pathway (Srayko et al., 
2000). Finally, katanin was also shown to participate in cilia biogenesis and in 
particular in the MT central pair assembly (Quarmby and Lohret, 1999; Sharma et 
al., 2007). 
In neurons, a large number of non-centrosomal microtubules are required for growth 
and maintenance of neuronal processes. Therefore, microtubule severing by katanin 
is essential for releasing microtubules from neuronal centrosome, and also for 
regulating the length of the microtubules after their release (Ahmad et al., 1999). In 
addition, katanin is likely to be the principal means for generating the short 
microtubules observed in axonal growth cones and interstitial branch points (Dent et 
al., 1999) (see Figure 1.7).  
 
Figure 1.7: Model for microtubule severing in axon. Potential sites of action of microtubule-severing 
enzymes are indicated by scissors. Microtubules growing from severed ends are shown in 
dark blue (Roll-Mecak and Vale, 2006). 
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Since katanin is abundant and widely distributed in neurons, it severs microtubules 
elsewhere but, it is locally activated and deactivated rather than, or in addition to, 
being recruited to sites where microtubules need to be severed (Karabay et al., 2004). 
Potential mechanisms that regulate katanin-mediated microtubule severing was 
illustrated in vitro (McNally et al., 2002),  tight regulation of the levels of katanin 
was observed in the neuron during axonal growth in vivo and high katanin levels was 
found in the rapidly growing axons but decreased rapidly once the target cells were 
introduced (Karabay et al., 2004). 
Since there is growing evidence that microtubules can be moved into new patterns of 
organization by forces generated by molecular motor proteins, a model called ‘cut 
and run’ is supported in which long microtubules are stationary, but relatively short 
microtubules are mobile. In this model, katanin break the lattice of the microtubule 
polymer in order to mobilize microtubules of cell. After being reorganized, the short 
microtubules can once again elongate and lose their mobility (Fig. 1.8). 
 
Figure 1.8: The ‘cut’ and ‘run’ model for microtubule reconfiguration (Baas et al., 2005). 
According to experiments it was suggested that fibrous MAPs protect the lattice of 
the microtubule from being severed by katanin and phosphorylation of this MAPs 
results in their release from microtubule and thus enable katanin to gain access. Not 
all MAPs, but tau was determined that it offers strong protection against severing by 
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either katanin or spastin that is another microtubule severing protein. Therefore, 
hyperphosphorylation of tau causes it to dissociate from microtubules so 
microtubules become more accessible to katanin and this process is also observed in 
Alzheimer’s disease pathology (Fig 1.9). 
 
Figure 1.9: Model for microtubule-based axonal degeneration in Alzheimer’s disease (Baas and  
                        Qiang, 2005). 
In a recent research, tau that shields microtubules from severing has been found that 
its protection is greater in the case of katanin (p60 subunit) than spastin (Yu et al., 
2008). 
1.4.3 Katanin subunits 
Katanin is a heterodimer protein composed of two subunits termed p60 and p80 
according to their molecular weight (McNally and Vale, 1993). The 60 kDa subunit 
is 491 amino acid long polypeptide (Karabay et al., 2004) and composed of an N-
terminal domain that binds microtubules (Hartman and Vale, 1999) and a C-terminal 
domain sharing homology with a large family of ATPases, the AAA family. The 80 
kDa subunit is 658 amino acid long (Karabay et al., 2004) and composed of an N-
terminal WD40 repeat domain, a central proline-rich domain and a C-terminal 
domain required for dimerization with the catalytic p60 subunit (Hartman et al., 
1998). 
It has been found that katanin’s p60 subunit exhibits both microtubule-stimulated 
ATPase activity and microtubule- severing activity in the absence of the p80 subunit 
The WD40 repeat domain of a human p80 homolog was shown to be sufficient to 
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target the p80 homolog to interphase centrosomes (Hartman et al., 1998). Then, it 
was found that the WD40 domain and con80 domain of p80 katanin as well as p60 
subunit are required for spindle pole targeting. Therefore, WD40 domain and con80 
domain of p80 katanin can enhance p60 mediated microtubule severing by increasing 
affinity of p60 to microtubules. However, it is also indicated that the WD40 domain 
of p80 might inhibit the microtubule-severing activity of p60 (McNally et al., 2000).  
As mentioned before, in neurons, the levels of P60-katanin, the enzymatic subunit, 
are very high in axons (Karabay et al., 2004) and they are also higher at the tips of 
growing neuronal processes at some developmental stages and are globally elevated 
at the developmental stage corresponding to dendritogenesis. In addition, katanin is 
typically viewed as a heterodimer, but it has been recently shown that the two 
subunits are not present within cells at equimolar levels. In fact, the ratio of the two 
subunits varies markedly in different tissues and at different stages of development, 
suggesting that the activity of the P60 subunit might be influenced by the levels of 
the P80 (Yu et al., 2005). These results support either suppressing or augment 
microtubule severing by different domains of p80 subunit (Baas et al., 2005). In 
addition, a recent research also reported that a candidate tumor suppressor 
LAPSER1/LZTS2 (LAPSER1) C terminal domain inhibits katanin-mediated 
microtubule severing in vitro by binding p80 katanin (Sudo and Maru, 2008). 
1.5 The Immune System 
The immune system is a bodywide network of cells, tissues, and organs that has 
evolved to defend the body against such "foreign" invasions. The immune system’s 
job is to keep foreign substances out or, failing that, to seek out and destroy them. 
The key to a healthy immune system is its remarkable ability to distinguish the 
structure between the body’s own and foreign molecules (Janeway et al., 2005). 
The cells in the immune system responsible for specifically targeting and causing the 
removal of foreign material or antigen are known as lymphocytes. They circulate in 
blood and lymph and populate areas of the body known as lymphoid tissues which 
include the spleen, lymph nodes, thymus, tonsils, adenoids, and Peyer's patches, the 
last three being located along the alimentary tract (Miller, 1996).  
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An introduction of a stimulus (immunogen or antigen) triggers the immune response 
to eliminate the provoking agent. An immunogen is a molecule that can induce an 
immune response in a particular host. The term “antigen” refers to the ability of a 
molecule to react with the products of adaptive immunity. Therefore, there are two 
levels of defense against invasion by external agents: innate immunity and adaptive 
immunity (Stites and Terr, 1991).  
Innate or natural immunity is present from birth, lacks specificity and memory, and 
consists of physical barriers such as skin and mucous membranes, certain enzymes 
(ex. Lysozyme) and phagocytic cells (ex. macrophages).  
The adaptive (or acquired) immune response is triggered by the presence of a foreign 
agent that escapes early elimination by the innate immune system. The components 
of the adaptive immunity are lymphocytes (T cells and B cells), plasma cells (end 
cells of B-lymphocyte differentiation) and antigen- presenting cells (macrophages, B 
cells and dendritic cells) (Stites and Terr, 1991; Ruebush, 2007). There are two broad 
immune response classes for adaptive immunity: Antibody responses and cell- 
mediated immune responses.  
In Antibody responses, B cells are activated to secrete antibodies, which are proteins 
called immunoglobulins. The antibodies circulate in the bloodstream and permeate 
the other body fluids, where they bind specifically to the foreign antigen that 
stimulated their production. Binding of an antibody inactivates viruses and microbial 
toxins by blocking their ability to bind to receptors on host cells. 
In cell mediated immune responses, activated T cells react directly against a foreign 
antigen that is presented to them on the surface of a host cell. The T cell, for 
example, might kill a virus-infected host cell that has viral antigens on its surface, 
thereby eliminating the infected cell before the virus had a chance to replicate. In 
other cases, the T cell produces signal molecules that activate macrophages to 
destroy the invading microbes that have phagocytosed.  
The adaptive immune system can remember prior experiences. Primary immune 
response is generated for the first exposure of an antigen then, secondary immune 
response of which lag period is shorter and the response is greater than the primary 
response if the same antigen is given again after some weeks, months or even years 
(Alberts et al., 2002). 
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1.6 Antibodies and Antigens 
Humoral immunity is mediated by a family of glycoproteins called antibodies. 
Antibodies specifically bind antigens in both the recognition phase and the effector 
phase of humoral immunity. Antibodies are produced in a membrane bound form by 
B lymphocytes, and these membrane molecules function as B cell receptors for 
antigens. The interaction of antigen with membrane antibodies on naive B cells 
initiates B cell responses and thus constitutes the recognition phase of humoral 
immune responses. Antibodies are also produced in a secreted form by antigen-
stimulated B cells.  
An antigen is any substance that may be specifically bound by an antibody molecule 
or T cell receptor. Antibodies can recognize as antigens almost every kind of 
biologic molecule, including simple intermediary metabolites, sugars, lipids, 
autacoids, and hormones, as well as macromolecules such as complex carbohydrates, 
phospholipids, nucleic acids, and proteins. Molecules that stimulate immune 
responses are called immunogens and all immunogens are also antigens, although the 
converse is not true.  
Only macromolecules are capable of stimulating B lymphocytes to initiate humoral 
immune responses. Low- molecular- weight (1000 to 10000 Da) compounds, 
including many drugs and antibiotics are nonimmunogenic so they are coupled to 
immunogenic proteins in order to generate specific antibodies.  In these cases, the 
small compound is called a hapten, and the macromolecule is called a carrier. The 
hapten-carrier complex, unlike free hapten, can act as an immunogen (Stites and 
Terr, 1991; Abbas and Lichtman, 2003; Ruebush, 2007).  In addition, the response to 
an immunogen can be enhanced if it is administered as a mixture with substances 
called adjuvants (Stites and Terr, 1991). 
Macromolecules are usually much bigger than the antigen-binding region of an 
antibody molecule. Therefore, any antibody binds to only a portion of the 
macromolecule, which is called a determinant or an epitope. Macromolecules 
typically contain multiple determinants, some of which may be repeated, and each of 
which, by definition, can be bound by an antibody ( Stites and Terr, 1991; Abbas and 
Lichtman, 2003).  
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1.6.1 Molecular structure of the antibody 
Proteins that have antibody activity called immunoglobulins. The two hallmarks of 
immunoglobulins are the specificity of each for one particular antigenic structure and 
their diversity as a group, which meets the challenge of a vast array of antigenic 
structures in the environment. Immunoglobulins are glycoproteins composed of 82- 
96 % polypeptide and 4-18 % carbonhydrate (Stites and Terr, 1991). 
Each antibody is an immunoglobulin tetramer consisting of two identical light (L) 
chains (each containing about 220 amino acids) and two identical heavy (H) chains 
(each usually containing about 440 amino acids). The four chains are held together 
by a combination of noncovalent and covalent (disulfide) bonds (Lewin, 2004; 
Alberts et al., 2002). Light chains and heavy chains share the same general type of 
organization in which each chain consist of two principal regions: the N-terminal 
variable region (V region); and the C- terminal constant region (C-region) (Fig. 
1.10).  
An immunoglobulin has a Y- shaped structure in which the arms of the Y are 
identical, and each arm has a copy of the variable domain (V) that is generated by 
association between the variable regions of the light chain and heavy chain. The V 
domain is responsible for recognizing the antigen. Production of hundreds number of 
V domains of different specificities creates the ability to respond to diverse antigens 
so the protein displays the maximum versatility in that region.  
The number of constant regions is vastly smaller than the number of variable regions 
(1-10 C region for any particular type of chain). The constant regions in the subunits 
of the immunoglobulin tetramer associate to generate several individual C domains 
that provide the effector response. The first domain results from association of the 
single constant region of the light chain (CL) with the CH1 part of the heavy- chain 
constant region. Two copies of this domain complete the arms of the Y- shaped 
molecule. 
The sequences coding for light chains and heavy chains are assembled in the same 
way: any one of many V gene segments may be joined to any one of a few C gene 
segments (see Figure 1.10). This somatic recombination occurs in the B lymphocyte 
in which the antibody is expressed. Therefore, V gene segments are responsible for a 
major part of the diversity of immunoglobulins (Lewin, 2004). 
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Figure 1.10: Structure of a typical immunoglobulin (antibody) protein. Bottom: Rearrangement of the 
light chain genes during B lymphocyte differentiation; Top: Rearrangement of the heavy 
chain genes (Url-1). 
1.6.2 Immunoglobulin isotypes and function 
In mammals, there are five classes of antibodies, IgA, IgD, IgE, IgG, and IgM, 
each with its own class of heavy chain- α, δ, ε, γ, and µ, respectively (Alberts et 
al., 2002). 
IgG, which has four subclasses (IgG1, IgG2, IgG3 and IgG4), having γ1, γ2, γ3, γ4 
heavy chains. IgG constitutes approximately 75 % of the total serum 
immunoglobulins so it is the dominant class in serum during a secondary immune 
response and the only one that crosses the placenta and confers immunity on the 
fetus (called passive immunity). It is also capable of fixing complement and 
promoting phagocytosis (opsonization) by reactivity with Fc receptors on 
leukocytes (Minn and Quintans, 1999, Alberts et al., 2002). 
IgA is the predominant immunoglobulin class in the mucosal immune system and 
appears to be an efficient antiviral antibody. IgA exists in two forms, IgA1 (90 
%) and IgA2 (10 %) that differ in the structure. IgA1 is composed like other 
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proteins, however in IgA2 the heavy and light chains are not linked with disulfide 
but noncovalent bonds. 
IgM is prominent in early immune responses to most antigens and predominates 
in certain antibody responses such as “natural” blood group antibodies. It is also 
exists in the pentameric form and is the major immunoglobulin expressed on the 
surface of B cells. IgM has µ heavy chains and is always the first class of 
antibody made by a developing B cell, although many B cells eventually switch 
to making other classes of antibody. The immediate precursor of a B cell, called a 
pre-B cell, initially makes µ chains which associate with so called surrogate light 
chains and insert into the plasma membrane. The complexes of µ chains and 
surrogate light chains are required for the cell to progress to next stage of 
development. The light chains combine with the µ chains, replacing the surrogate 
light chains, to form four-chain IgM molecules. These molecules then are 
inserted into the plasma membrane, where they function as receptors for antigen. 
At this point, the cell is called an immature B cell. 
IgD is a monomer and is normally present in serum in trace amounts. IgD (with 
IgM) is the predominant immunoglobulin on the surface of B lymphocytes at 
certain stages of their development and it has been suggested that IgD may be 
involved in the differentiation of these cells.  
IgE is responsible for many common allergies. It binds to receptors on mast cells 
and triggers degranulation of the cells upon contact with antigen. IgE may protect 
against parasitic infections. The tail region of IgE molecules, which are four-
chain monomers, binds with unusually high affinity to Fc receptors of mast cells 
in tissues and of basophils in the blood. Antigen binding triggers these cells to 
secrete a variety of cytokines and biologically active amines, especially histamine 
(Stites and Terr, 1991; Alberts et al., 2002, Abbas and Lichtman, 2003). 
 
1.7 Monoclonal Antibodies 
Monoclonal antibodies are produced by hybridoma cell lines and can be grown in 
tissue culture in the laboratory. Hybridomas are recombinant cell lines produced 
from the fusion of B cell clones derived from the lymphatic tissue of donor 
animals and a myeloma cell line that imparts immortality to the cells. Hybridoma 
Technology is used for production of monoclonal antibodies. In this technique, 
the idea is combining two useful cells together
from a single B cell clone
and immunoglobulin type, and is thus
Each monoclonal antibody is monospecific and will recognize only one epitope 
on the antigen to which it has been raised. This may lead to practical problems if 
the epitope is not highly conserved on the native protein or where conformational 
changes may occur 
Monoclonal antibodies are highly specific and will rarely if ever produce cross
reactions with other 
Because of the high degree of specificity in antibody mediated recognition, the 
clinical usefulness of monoclonal antibodies has long been recognized. 
Applications of monoclonal antibodies include cancer, allograft rejection, 
autoimmunity, tissue damage, diagnostic imaging, etc.
In the case of cancer, antibodies can be used to target 
determinants found on tumors and mark their destruction. Antibody therapy of 
cancer relies on enhancing various natural
interfering with cell function
antibodies that are used for 
Figure 1.11: Therapeutic monoclonal antibodies approved for use in oncology
                         Weiner et al.
In cases of allograft rejection and 
the immune system to the point where it does not reject the targeted tissue. 
Lymphocyte activation requires T cell receptor engagement and a
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approved for clinical use, binds a T cell signaling molecule called CD3 and acts 
as an immunosuppressant by blocking T cell receptor signaling. 
 Drug toxicity and gram negative sepsis can be treated by using antibodies that 
can bind and neutralize the toxin. An antibody against the lipid a domain of 
endotoxin can reduce mortality in patients with Gram-negative bacteremia. 
Infiltrating leukocytes secreting cytokines and inflammatory mediators often 
cause tissue damage. Antibodies specific for leukocyte adhesion molecules such 
as LFA-1 or ICAM-1, can reduce tissue damage by preventing the accumulation 
of leukocytes (Minn and Quintants, 1996). 
Monoclonal antibodies can be used to treat viral diseases. For example, a 
monoclonal antibody against shope fibroma virus superoxide dismutase is used in 
diagnostics and as tools to understand the role of SOD-like proteins in 
pathogenesis (Shahhosseini et al., 2006). 
Researchers use monoclonal antibodies to identify and trace specific cells or 
molecules in an organism. For example, scientists have produced a monoclonal 
antibody appears to be a powerful probe in the study of smooth muscle 
differentiation in normal and pathological conditions (Skalli, 2008). 
Monoclonal antibodies that are used in methods of research and clinical 
applications are summarized in Figure 1.12. 
 
Figure 1.12: Application areas of monoclonal antibodies. bELISA, enzyme-linked immunosorbent 
assay; ELISPOT, enzyme-linked immunospot assay; FACS, fluorescence-activated cell 
scanning; MACS, magnetic-activated cell sorting; PET, positron emission tomography; 
SPECT, single photon emission computerized tomography (Lipman et al., 2005). 
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1.7.1 Monoclonal antibody production: hybridoma technology 
Tremendous progress in the development, characterization, and manufacturing of 
monoclonal antibodies (MAbs) has been made since 1976, the year when George J. 
F. Kohler and Cesar Milstein published their seminar paper on the production of 
MAbs by producing hybrids between mouse splenocytes with their myeloma fusion 
partner. Kohler’s and Milstein’s outstanding contribution, for which they were 
awarded together with Niels K. Jerne the 1984 Nobel Prize in Physiology or 
Medicine, and—beyond all—their deliberate decision not to patent the hybridoma 
technology resulted in the rapid and widespread adoption of MAbs by both academia 
and industry (Mechetner, 2007). 
Hybridomas are hybrid cells derived from the fusion of immortal myeloma cells with 
B-lymphocytes taken from the spleen of animals immunized with the target antigen. 
After limiting dilution cloning, hybridomas represent a pure and indefinite source of 
monoclonal antibodies with the desired target specificity (Chiarella and Fazio, 2008). 
In Hybridoma Technology people can take advantage of three pieces of information: 
1-) B lymphocytes are blood cells which can produce and secrete antibody for 
specific epitope, and can have a limited life time up to 4-5 days.  
2-) Myeloma cells are the immortal cells that lose their reproduction control 
mechanism. 
3-) By combining two different cells from the same organism in a specific 
conditions, hybridomas carrying features of the two cell can be produced. 
Steps of the hybridoma technology are shown below, 
• In order to produce antibody against the desired antigen, mice are immunized 
with desired antigen. Then, the most actively immunized mouse is selected by 
ELISA method.  
• The most actively immunized mouse’s spleen is taken to isolate antibody 
producing B lymphocyte and myeloma cells are prepared.  
• To produce hybridoma, polyethylenglycol (PEG) is used to fuse two types of 
cells. 
• Cells that are subjected to fusion in a culture medium will then be incubated in 
Hypoxanthine Aminopterin Thymidine medium (HAT medium) waiting unfused 
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Cells to die. Meanwhile, remained hybridomas are continuing to divide in culture 
plates. 
• Hybridoma clones that produced antibodies for desired antigen are detected by 
ELISA method. 
• In this stage, there can be more than one hybridoma colony in a well which can 
produce polyclonal antibody. By using “limited dilution” method, selected cells 
in wells are dispersed to new culture plates in order to get hybrids (immortal B 
lymphocyte) from the origin of single cell. 
• Hybridoma colonies that synthesize specific antibody for desired antigen can be 
selected by ELISA method. 
• Selected hybridomas produce large quantities either in vivo (by formation 
ofascites in mouse) or in vitro (in cell culture). 
• Produced antibodies could be purified with appropriate methods (Saatçılar, 
2008). 
 
Figure 1.13: General steps of generation monoclonal antibodies, adapted from Url-2. 
1.7.1.1 Features of chosen animals for immunization 
Mice and rats are preferred for monoclonal antibody production in hybridoma 
technology since they are easy to obtain, inexpensive to get and they both give good 
response to immunization. Usually, Balb/c mice strains are used because of their 
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positive response against to desired antigen, like greater ascites volumes and 
antibody production (Lidell and Cryer, 1991). 
It is crucial to use young adult animals such as 6-8 weeks old whose immune 
response is robust and not affected by previous immune challenges in order to 
increase immune response with desired antigen.  Although mice are inbred, they are 
not genetically similar with each other so their immune response will be different. 
Moreover, mice can die for different reasons in this immunization period. In order to 
prevent this kind of side effects, 6-8 weeks old mice are selected. 
If the sex of the animals is taken into account, female ones are preferred because they 
can be group housed more successfully than males that are more aggressive and 
naughty in social interaction (Hau and Hendriksen, 2003). However, male animals 
are used in some research, as well.  
In addition, it is important to consider the health status of animals that are used for 
production of antibodies since infectious agents may suppress, modulate, or stimulate 
the immune system. Usage of disease free animals decreases the liability of cross- 
reactivity to other antigens (Leenaars and Hendriksen, 2005). 
1.7.1.2 Features of cells for fusion 
The choice of rat or mice strains for use in monoclonal antibody production is 
normally constrained by the source from which the myeloma cell lines were derived. 
Therefore, Balb/c mouse strain is preferred. Since, myeloma cell lines have been 
derived from originally induced such mice; they are so compatible for the 
propagation of hybridoma cells in vivo. 
For monoclonal antibody production, only the myeloma cell lines are used which 
could not have a capacity to secrete immunoglobulins of their own. It reduces the 
proportion of hybrids which potentially will secrete lymphocyte derived antibodies. 
For the first time, a non-immunoglobulin producing mouse myeloma cell line was 
isolated by Schulman et al. in 1978. The line, known as Sp/0-Ag14, showed a 
variable efficiency of fusion although it was recognized as potentially useful partner 
for generating hybridomas making truly monoclonal antibodies. Kearney et al. 
identified another mouse myeloma cell line (X63- Ag8- 653) in 1979 that had lost 
22 
 
the capacity for immunoglobulin expression but which still permitted the formation 
of antibody secreting hybrid cell lines (Lidell and Cryer, 1991). 
1.7.1.3 Post fusion selection criteria for cells 
As mentioned before, B lymphocytes derived from immunized mice have limited life 
span in vitro so they need to be immortal. It is accomplished by fusion them with 
immortal myeloma cells. After this step, it is required to select mixed hybrids other 
than different hybrid cells in the environment such as B lymphocyte- B lymphocyte 
hybrid cells, myeloma-myeloma hybrid cells, non-fusion of B lymphocyte cell. In 
order to select the endless monoclonal antibody production ability of myeloma- B 
lymphocyte hybrids from others, all the cells are incubated by a selection medium 
such as HAT ( Hypoxanthine Aminopterin Thymidine) medium that is the most 
common selection medium used in the production of hybridomas. 
Normal animal cells can synthesize nucleotides from small-molecule precursors (de 
novo pathway) or from the partial breakdown products of nucleic acids (salvage 
pathway). The salvage pathway relies on the presence of the enzyme hypoxanthine 
guanine phosphoribosyl transferase (HGPRT) (Fig 1.14). 
The mouse myeloma cell line P3-X63-Ag8.653 is an HGPRT deficient (HGPRT−) 
mutant strain. This feature, along with a high fusion frequency, provides this line of 
cells with a benefit to be used as a fusion partner to generate hybridoma cells. Since 
HGPRT+ cells are resistant to antifolates such as aminopterin in the presence of 
hypoxanthine and thymidine, HGPRT− cells are selectively cytotoxic in response to 
aminopterin (Chung et al., 2000). Therefore, unfused myeloma cells die as they 
cannot produce nucleotides by de novo or salvage pathway and unfused B cells die 
as they have a short life span in HAT medium. In this way, only the B-cell-myeloma 
hybrids survive. 
Figure 1.14: De novo and salvage pathways for 
After the fusion in HAT culture medium, myeloma/ myeloma hybrid cells and 
unfusioned myeloma cells 
Unfusioned B lymphocyte cells and B lymphocyte/ B lymphocyte hybrid cells die in 
4-5 days because of not having immortality feature. Thus, required myeloma/ B 
lymphocyte hybrid cells are selected from the other hybrids.
Figure 1.15: Post fusion cell features in HAT medium
1.7.1.4 Immune response detection: ELISA
The initial description of the enzyme
30 years ago marked a technological advance that has had an immense impact in 
both clinical diagnostic and basic scientific applications. This assay represents a 
simple and sensitive technique for specific, quantitative detection of molecules to 
which an antibody is available
antigen immobilized on a
covalently coupled enzyme. The amount of antibody that
nucleotide synthesis (Lodish et al., 
disappear from the culture in 8-9 days (Table
 
 (Lidell and Cryer, 1991).
 
-linked immunosorbent assay (ELISA) almost
 (Jordan, 2002). ELISA is a method of quantifying an 
 solid surface by use of a specific antibody with a 
 binds the antigen is 
 
2003). 
 1.3). 
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proportional to the amount of antigen present and is determined by 
spectrophotometrically measuring the conversion of a clear substrate to a colored 
product by the coupled enzyme (Abbas and Lichtman, 2003).  
ELISA is also appropriate for use for screening hybridoma supernatants. Since 
cheapness, availability, and stability of substrate are important considerations, the 
most commonly used enzymes are alkaline phosphatase, β-D-galactosidase, and 
horseradish peroxidase (Page and Thorpe, 2002). 
There are four types of ELISA systems: indirect, direct, competitive and sandwich 
ELISA (Pierce Handbook, 2009). The principle of these ELISA systems is illustrated 
in Figure 1.16. 
 
 Figure 1.16: ELISA formats (Pierce Handbook, 2009). 
1.7.2 Comparing of polyclonal and monoclonal antibodies 
The decision regarding whether to use a polyclonal antibody (PAb) or monoclonal 
antibody (MAb) depends on a number of factors, the most important of which are its 
intended use and whether the antibody is readily available from commercial suppliers 
or researchers. PAbs can be generated much more rapidly, at less expense, and with 
less technical skill than is required to produce MAbs. One can reasonably expect to 
obtain PAbs within several months of initiating immunizations, whereas the 
generation of hybridomas and subsequent production of MAbs can take up to a year 
or longer in some cases, therefore requiring considerably more expense and time. 
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The principal advantages of MAbs are their homogeneity and consistency. The 
monospecificity provided by MAbs is useful in evaluating changes in molecular 
conformation, protein-protein interactions, and phosphorylation states, and in 
identifying single members of protein families. It also allows for the potential of 
structural analysis (e.g., x-ray crystallography or gene sequencing) to be determined 
for the antibody on a molecular level. However, the monospecificity of MAbs may 
also limit their usefulness. Small changes in the structure of an epitope (e.g., as a 
consequence of genetic polymorphism, glycosylation, and denaturation) can 
markedly affect the function of a MAb. For that reason, MAbs should be generated 
to the state of the antigen to which it will eventually need to bind. In contrast, 
because PAbs are heterogeneous and recognize a host of antigenic epitopes, the 
effect of change on a single or small number of epitopes is less likely to be 
significant. PAbs are also more stable over a broad pH and salt concentration, 
whereas MAbs can be highly susceptible to small changes in both. Another key 
advantage of MAbs is that once the desired hybridoma has been generated, MAbs 
can be generated as a constant and renewable resource. In contrast, PAbs generated 
to the same antigen using multiple animals will differ among immunized animals, 
and their avidity may change as they are harvested over time. The quantity of PAbs 
obtained is limited by the size of the animal and its lifespan. However, the 
concentration and purity levels of specific antibody are higher in MAbs. In 
comparison, MAbs generated as ascites or in specialized cell culture vessels are 
frequently 10-fold higher in concentration and of much higher purity. MAbs are not 
generally useful for assays that depend on antigen cross-linking (e.g., 
hemagglutination) unless dimeric or multimeric antigens or antigens bound to a solid 
phase are used. Additionally, they may not activate complement complement readily 
because activation requires the close proximity of Fc receptors. Modification of 
antibodies by covalently linking a fluorochrome or radionuclide may also alter 
antibody binding. Many of the disadvantages of MAbs can be overcome by pooling 
and using multiple MAbs of desired specificities. The pooled product is consistent 
over time and available in limitless quantity (Lipman et al, 2005).  
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1.8 Aim of the Study 
Katanin is a microtubule severing protein consisting of 2 subunits; catalytic p60 
subunit and regulatory p80 subunit. Catalytic p60 subunit is a member of AAA 
ATPases. Regulatory subunit p80 is involved in the targeting of katanin into 
centrosomal site where it functions.   
Katanin and its orthologs are found and a number of organisms: sea urchin, Xenopus 
laevis, Drosophila melanogaster, Caenorhabditis elegans, rat, human. This 
microtubule severing protein has an important role in processes where microtubules 
are reorganized.   
In mitotic cells, microtubule severing by katanin on the spindles is thought to 
contribute to spindle reorganization. Microtubule severing may also play roles in the 
specific activities on differentiated cells such as myocytes, epithelial cells and 
neurons.  
In postmitotic neurons, axonal differentiation such as elongation, branching, 
navigation, retraction is accomplished by microtubule severing. In addition, tight 
regulation of the levels of katanin was observed in the neuron during axonal growth 
in vivo and high katanin levels was found in the rapidly growing axons but decreased 
rapidly once the target cells were introduced. Katanin levels are also higher at the 
tips of growing neuronal processes at some developmental stages and are globally 
elevated at the developmental stage corresponding to dendritogenesis. Therefore, 
katanin may also comprise a function in regeneration of neuronal injuries. The 
damaged microtubules may be replaced with healthy microtubules via microtubule 
severing. Relation of katanin with neurodegenerative diseases is possibly proved 
with this hypothesis.  
Besides the all studies about properties and functions of katanin, it is still not 
identified interacting proteins of katanin p60. Finding out this issue will help to 
understand which proteins in signal transduction pathway are involved in the 
regulation of microtubule severing. Techniques such as immunostaining, western 
blotting and immunoprecipitation could be used for observing cellular katanin p60. 
Since these techniques are mainly based on interaction of desired protein and 
antibody binding, some problems growing out of non-specific or inefficient binding 
of primary antibody can come out. In order to manage these problems, monospecific 
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antibodies can be used as primary antibodies. In this case, the amino acid sequence 
of recombinant katanin p60 should be specific and include an antigenic region. 
Therefore, produced monoclonal antibodies against this kind of katanin p60 protein 
are expected to give more efficient results in further observing cellular katanin p60. 
In addition, the protein that is expressed should be soluble to immunize mice 
efficiently.  
In this study, it is aimed to express recombinant katanin p60 protein with taking into 
account subjects mentioned above and produce monoclonal antibodies against 
recombinant katanin p60 by hybridoma technology for further usage in western 
blotting, immunostaining and immunoprecipitation assays.  
1.8.1 Rattus norvegicus katanin p60 amino acid sequence 
Katanin p60 was cloned and expressed in order to use the protein in monoclonal 
antibody production. An amino acid sequence of katanin p60 which is specific was 
selected by using National Center for Biotechnology Information (NCBI) protein 
blast tool (Url-4). The selected sequence of katanin p60 is 73 amino acid length 
(amino acids 98-170). Since a polyclonal antibody against katanin p60 (amino acids 
115-148) is produced and it recognizes the katanin p60 protein in brain cells 
efficiently (Karabay et al., 2004), the selected amino acid sequence in this study is 
thought to have an antigenic region. The sequence of full rat katanin p60 and the 
selected region is given below. 
 
Figure 1.17: Rattus norvegicus katanin-p60 amino acid sequence (retrieved from NCBI database, 
accession number NP_001004217). The sequence of p60 that is shown in bold was 
cloned and expressed; underlined part of p60 is the conserved C- terminal AAA 
domain. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Lab equipments 
The equipments used in the study are given in the table 2.1: 
Table 2.1: Laboratory equipments used in the study 
Equipment Supplier Company 
Centrifuges Biolab SIGMA 6K15, Beckman Coulter 
Microfuge®18, Beckman Coulter AvantiTM J-30 I, 
IECCL10 Centrifuge,  
Thermo Electron Corporation, Labnet, Labnet 
International C1301-230V 
DNA sequencer Applied Biosciences 3100 Avant 
High pressure steam sterilizer TOMY SX-700E 
Magnetic stirrer Labworld Standard Unit 
pH Meter Mettler Toledo MP220 
Precision Weigher Precisa 620C SCS 
Weigher Precisa BJ 610 C 
UVIPhoto MW Version 99.05 for Windows 
95 & 98 
UVItec Ltd. 
UV Transilluminator Biorad UV Transilluminator 2000 
Electrophoresis equipments ThermoEC MiniCell® PrimoTM 
EC320 Electrophoretic Gel System 
Power supply EC250-90 Apparatus Corporation 
Microwave Arçelik MD582 
Ice machine Scotsman AF 10 
Vortex Heidolph, Reaxtop 
Water Baths Memmert, Elektro-mag M 96 KP 
Thermomixer Eppendorf Thermomixer Comfort 
Laminar air flow cabinets FASTER BH-EN 2003 
Incubator with CO2 Biolab SHEL LAB 
UVIPhoto MW Version 99.05 for Windows 
95 & 98 
UVItec Ltd. 
UV Transilluminator Biorad UV Transilluminator 2000 
Inverted light microscope Olympus CK40 
Thermal Cycler Techne TC-3000 
Elisa washing device Nunc-ImmunoTM Wash8 
SDS-PAGE gel electrophoresis system BIO-RAD MiniProtean 
Power supply  Thermo Electron Corporation EC250-90 
Shaker Forma Orbital Shaker,  
Thermo Electron Corporation 
Freezers UĞUR (-20oC), UĞUR (+4 oC), New Brunswick 
Scientific (-80 oC) 
UV-Visible Spectrophotometers uv-1700 PharmaSpec Shimadzu, Thermo scientific 
nanodrop 1000 
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Table 2.1 (contd.) : Laboratory equipments used in the study 
Microplate Spectrophotometer BIORAD Benchmark Plus 
Pure water system TKA Wasseraufbereitungssysteme 
Mini Blot Module Thermo Electron Corporation EC140 
Syringe filters 0.22µm, TPP 
Vacuum filtration- system 150ml, TPP 
Pipettes 2.5µl, 10µl, 100µl, 200µl,  Eppendorf 1000µl,   
Finnpipette Thermo 
Electronic pipette Finnpipette Thermo  
Multichannel (12 channel) pipette 50-300µl, Genex beta 
Microfuge tubes  1.5ml, 2ml, Axygen 
Centrifuge tubes  15ml, 50ml Avant Plus 
ELISA plate  96well, Nunc 
Tissue culture test plates 6 well, 12 well, 96 well, TPP 
Tissue culture flasks 25 cm2, 75cm2, 150cm2, TPP 
Cell Scraper 30cm, TPP 
Hemacytometer Fisher Scientific 
Injectors 2ml, inject, 1ml, tuberculin 
Serological pipette TPP 
PVDF membrane Roche 
3MM Whatman Filter Paper Whatman 
2.1.2 Chemicals and enzymes 
Chemicals and enzymes used in the study are shown in the table 2.2: 
Table 2.2 Chemicals and enzymes 
Material Supplier Company 
EcoRI restriction enzyme 
HindIII restriction enzyme 
MassRuler™ DNA Ladder (Mix, 80bp-10Kb) 
Mass Ruler Low Range DNA Ladder (80-1031 bp) 
10 mM dNTP mix  
2 mM dNTP mix 
10 X Pfu  DNA polymerase Buffer (with MgCl2) 
10X Tango Y buffer 
25 Mm MgCl2  
10X Y+ Tango buffer 
6X Loading dye 
Fermentas 
T4 DNA Ligase Buffer  
T4 Ligase  
NBT/ BCIP Stock Solution  
Roche 
SeeBlue Plus2 Prestained Protein Ladder Invitrogen 
Primer T7 promoter 
Primer T7 terminator 
Integrated DNA Technologies 
IPTG 
Low melting agarose 
TEMED 
AppliChem 
NaH2PO4.2H2O 
KH2PO4 
K2HPO4  
NaAc 
J.T. Baker 
Tryptone Lab M TM 
Isopopanol 
Glycerol 
PEG 8000 
Coomassie Brilliant Blue 
 
 
Fluka 
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Table 2.2 (contd.): Chemicals and enzymes 
Kanamycin 
Tween20 (P9416) 
Albumine, bovine (BSA) 
Freund’s complete adjuvant 
Freund’s incomplete adjuvant 
Anti-Mouse IgG (γ-chain specific)- Alkaline Phosphatase 
antibody produced in goat  
Anti-Mouse Polyvalent Immunoglobulins (G,A,M)−Alkaline 
Phosphatase antibody produced in goat 
N,N’- Dimethyl- bis- Acrylamide 
4-Nitrophenyl phosphate di (tris) salt 
 
 
 
 
Sigma 
Anti-His penta monoclonal Mouse antibody 
50% Ni-NTA agarose suspension 
Qiagen 
PIPES  
Tris Base 
Acrylamide 
 
BDH Laboratory 
DMSO 
ZnCL2 
Acetone 
Absolute methanol  
Absolute ethanol 
 
Riedel- de Haёn 
Diethyl ether LACHEMA 
Glisin 
Boric acid 
APS 
CaCl2.2H2O 
EDTA 
SDS 
Glucose 
Ethidium bromide 
Yeast Extract 
Agar  
KCl 
Imidazole 
PEG 4000 
DTT  
HCl 
Bromophenol blue 
 
 
 
 
 
Merck 
MgCl2.6H2O  
NaCl 
CARLO ERBA 
Skimmed milk powder PINAR 
DMEM- High Glucose- Liquid Media (SH30243) HyClone 
FBS Biochrom 
Gentamicin 
HT Supplement (100X) 
HAT Supplement (50X) 
 
Gibco 
2.1.3 Commercial kits 
Commercial kits used in this study are given in the table 2.3: 
Table 2.3: Commercial kits 
Kit Supplier Company 
QIAquick PCR purification kit Qiagen, 28104 
QiaPrep Spin Miniprep Kit Qiagen, 27106 
Big Dye Terminator v 3.1 Cycle Sequencing Kit Applied Biosystems 
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2.1.4 Buffers and solutions 
2.1.4.1 TBE buffer (10X)  
Commercially available 10X TBE buffer (Dr. Zeydanlı) was used in agarose gel 
electrophoresis to prepare the agarose gel that DNA loaded on and as the tank buffer. 
10X TBE buffer was used by diluting to 1X TBE buffer with dH2O. 
2.1.4.2 Protein purification buffers 
 Protein purification buffers were used for purifying proteins from bacterial pellet by 
metal affinity chromatography. Buffer types and their preparations are given below: 
Lysis buffer: 78 miligram (mg) NaH2PO4.2H2O (50mM), 175.4 mg NaCl (300mM) 
and 6.8 mg imidazole (10 mM) were dissolved in 10 ml distilled water (dH2O) and 
pH is adjusted to 8.0 using NaOH. 
Wash buffer: 78mg NaH2PO4.2H2O (50 mM), 175.4mg NaCl (300 mM) and 13.6 
mg (20mM) were dissolved in 10 ml distilled water (dH2O) and pH is adjusted to 8.0 
using NaOH. 
Elution buffer: 39 mg NaH2PO4.2H2O (50 mM), 87.7 mg NaCl (300 mM) and 
2.72 gram (g) (4 M) were dissolved in 5 ml distilled water (dH2O) and pH is adjusted 
to 8.0 using NaOH. 
2.1.4.3 Buffers and solutions for SDS- PAGE analysis  
2X sample buffer: 2X sample buffer was used to denature protein samples which 
were loaded on SDS- polyacrylamide gel. Preparation of 2X sample buffer is shown 
in Table 2.4. 
Table 2.4: Preparation of 2X sample buffer 
Content Concentration Amount 
Tris- HCl pH:6.8 0.125 M 2.5 ml (of 0.5 M) 
SDS 4 % 4 ml (of 10%) 
Glycerol 20 % 2 ml (of 100 %) 
Bromophenol blue 0.05 % 5 mg  
DTT 0.15 M 231 mg 
dH2O  up to 10 ml 
Tris- Glycine running buffer (pH: 8.3): Tris- glycine buffer was used to reduce pH 
of the solution changes. Preparation of Tris- glycine buffer is shown Table 2.5. 
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Table 2.5: Preparation of Tris- Glycine running buffer 
Content Concentration Amount 
Tris- HCl 0.125 M 3 g 
Glycine 0.192 M 14.4 g 
SDS 0.1 % 10 ml (of 10 %) 
dH2O  up to 1 liter 
Coomassie Brilliant Blue (CBB) stain solution: CBB stain solution was used to 
visualize separated protein bands on SDS polyacrylamide gel. Preparation of CBB 
stain solution is shown below: 
Table 2.6: Preparation of CBB stain solution 
Content Concentration Volume 
CBB R-250 
Methanol 
Acetic acid 
dH2O 
0.1 % 
50 % 
10 % 
 
0.5 g 
250 ml 
50 ml 
up to 500 ml 
Destain solution: Destain solution was used to visualize protein bands clearly by 
removing the background on SDS polyacrylamide gel. Preparations of CBB destain 
solution is shown below: 
Table 2.7: Preparation of CBB destain solution 
Content Concentration Volume 
Methanol 
Acetic acid 
dH2O 
5 % 
10 % 
50 ml 
100 ml 
up to 1 liter 
2.1.4.4 Buffers for western blot analysis 
Transfer buffer: Transfer buffer was used to reduce pH of the solution changes 
during transferring protein bands from SDS polyacrylamid gel to PVDF membrane. 
Preparation of transfer buffer is given Table 2.8. 
Table 2.8: Preparation of transfer buffer 
Content Concentration Amount 
Tris 
Glycine 
Methanol 
SDS 
dH2O 
25 mM 
192 mM 
20 % 
0.05 % 
3 g 
14.4 g 
200 ml 
0.05 g 
1 liter 
TBS 1X:  TBS (with HCl) was used to maintain the pH within the 7 - 9.2 range 
during preparing blocking and washing buffers. Preparation of TBS is given Table 
2.9.  
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Table 2.9: Preparation of TBS 
Content Concentration Amount 
NaCl 
KCl 
Tris 
dH2O 
0.8 % 
0.02 % 
0.3 % 
2.4 g 
0.06 g 
0.9 g 
300ml, pH: 7.4 
TTBS: Preparation of TTBS is given below: 
Table 2.10: Preparation of TTBS 
Content Concentration Amount 
Tween 20  
TBS 
0.05 % 90 µl 
180 ml 
NBT/ BCIP substrate buffer: NBT/ BCIP substrate buffer was used for preparing 
NBT/BCIP staining solution to detect alkaline phosphatase. Preparation of this buffer 
is given below: 
Table 2.11: Preparation of NBT/ BCIP substrate buffer 
Content Concentration Amount 
Tris-HCl pH: 9,5 
NaCl 
MgCl.6H2O 
dH2O 
0.1 M 
0.1 M 
0.05 M 
3 g 
1.461 g 
2.541 g 
250 ml 
2.1.4.5 Buffers for cell culture and ELISA assays 
PBS buffer: 10 Mm KH2PO4 was prepared and 10 mM K2HPO4 was added to 
balance pH of buffer to 7.2. Then, 0.15 M NaCl was added. 
PBS- Tween 20 buffer: 0.05 % tween 20 was added to PBS buffer. 
PEG solution: 2 g PEG-4000 was mixed with 2 ml dH2O and then sterilized by 
autoclave. After sterilization, it was kept at 37oC. 
Substrate buffer: 1 mM ZnCl, 1 mM MgCl and 0.1 M glycine was dissolved in 
dH2O and pH was balanced with KOH to 10.4. 1 mg PNPP was added to 1 ml 
substrate buffer before used and it was kept at dark. 
2.1.5 Bacterial strains 
Escherichia coli (E.coli) DH5α strain [F-, φ80dlacZ∆M15, ∆(lacZYA-argF)U169, 
deoR, recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1], 
Invitrogen. 
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Escherichia coli strain BL21 (DE3)pLysS F– dcm ompT hsdS(rB– mB–) gal (DE3)[pLysS 
Camr], Novagen. 
2.1.6 Bacterial culture media 
LB medium was prepared by dissolving 10 g tryptone, 5 g yeast extract, and 10 g NaCl 
in 1 liter distilled water. The media was sterilized by autoclaving at 121oC for 15 
minutes (min). After sterilization, antibiotic was added to the LB medium according 
to the concentration mentioned in Table 2.12 in order to make selection media. 
LB- agar plate was prepared by adding 15 g/L of agar to LB medium and sterilized 
autoclaving as describe above. 
SOC medium was used to cultivate E. coli cells for 1 hour after heat shock during 
transformation. It was prepared by dissolving 2 g tryptone, 5 g yeast extract, 0.058 g 
NaCl, 0.0186 g KCl, 0.095 g MgCl2, 0.23 MgSO4 and 0.36 g glucose in 100 ml 
distilled water and sterilized at 121 °C with autoclaving for 15 min. 
Table 2.12: Stock and working solutions of antibiotics 
Antibiotic Stock Solution 
Concentration 
Working Solution 
Concentration 
Kanamycin 30 mg/ml in distilled water 30 µg/ml 
2.1.7 T/A cloning vector with cloned insert 
pCR 2.1- TOPO (Invitrogen) vector that contains full length of katanin p60 subunit 
was previously designed by Assoc. Prof. Dr. Arzu Karabay Korkmaz. The cloned 
katanin p60 subunit was in reverse direction in this vector (see Fig 2.1). 
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Figure 2.1: Vector map of pCR 2.1- TOPO with cloned insert. Cloning/restriction area with 
schematically    represented insert is shown in a larger scale. Arrow stretching from PCR 
product point is at the part of cloned p60 subunit (beginning and end of the sequence) in a 
large scale. At the bottom-left part of the picture part of normally oriented p60 is shown 
in italic. 
2.1.8 Expression vector 
2.1.8.1 pET expression system 
We have chosen pET expression system which is the most powerful system yet 
developed for the cloning and expression of recombinant proteins in E. coli because 
large amounts of recombinant protein could be expressed in a short time in this 
expression system. In addition, this system has the lowest basal expression levels of 
any E.Coli expression system. This issue would be critical if the expressed protein is 
toxic for the host cell. 
Unlike systems based on E. coli promoters (e.g., lac, tac, pL), the pET System uses 
the bacteriophage T7 promoter to direct the expression of target genes. Since E. coli 
RNA polymerase does not recognize the T7 promoter, there is virtually no 
transcription of the target gene in the absence of a source of T7 RNA polymerase 
(Mierendorf et al., 1994). Moreover, bacteriophage T7 RNA polymerase is a 
processive enzyme that will transcribe around a circular plasmid several times and 
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therefore transcribe genes that are not efficiently transcribed by E.coli RNA 
polymerase (Sambrook and Russell, 2001). 
Typically, production hosts contain a prophage (λDE3) encoding the T7 polymerase 
under control of the IPTG- inducible lacUV5 promoter. While this system leads to 
the synthesis of large amounts of mRNA and in most cases, the concomitant 
accumulation of the desired protein at very high concentrations (40–50 % of the total 
cell protein), it is not without drawbacks. For example, high level of mRNA can 
cause ribosome destruction and cell death, and leaky expression of T7 RNA 
polymerase may result in plasmid or expression instability. Furthermore, even 
‘empty’ pET plasmids are toxic to E. coli in the presence of IPTG. For this reason, 
target genes are initially cloned using hosts that do not contain the T7 RNA 
polymerase gene, thus eliminating plasmid instability due to the production of 
proteins potentially toxic to the host cell. For more stringent control, hosts carrying 
either pLysS or pLysE (Novagen) plasmids are available. The pLys plasmids encode 
T7 lysozyme, which is a natural inhibitor of T7 RNA polymerase and thus, reduces 
its ability to transcribe target genes in uninduced cells (Mierendorf et al., 1994; 
Baneyx, 1999).  
Host and vector elements that are avaible for control of T7 RNA polymerase levels 
and subsequent transcription of a target gene cloned in a pET vector were illustrated 
in Figure 2.2. 
 
Figure 2.2: Control elements of the pET system (Mierendorf et al., 1994) 
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2.1.8.2 pET-30a vector 
The pET-30a(+) (Novagen) vector was kindly provided by Dr. Stephan Scheurer 
(Paul-Ehrlich-Institute, Dept. of Allergology). The pET-30a (+) vector carries an N-
terminal His•Tag®/thrombin/S•Tag™/enterokinase configuration plus an optional C- 
terminal His•Tag sequence. The circular map (Fig. 2.3) and the cloning/expression 
region (Fig. 2.4) are shown below. The vector is 5422 bp long. 
 
Figure 2.3: Vector map of pET30a (Url-5). 
 
Figure 2.4: Cloning/expression region of the coding strand of pET30a (Url-5). 
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2.1.9 Cell culture media 
Dulbecco’s Modified Eagle Medium (DMEM-Gibco) was prepared by dissolving 
3.5 g glucose, 2g NaHCO3 and 15.4 g DMEM powder (with 1g/L glucose and 25 
mM Hepes) in 1 liter distilled water and adjusted to pH 7.2 by NaOH, then filtered 
by 0.2 µm filter to obtain sterilization. It was stored at +4oC.  
Growing medium was used for F0 myeloma cells and produced hybrid cells from 
fused F0 cells. It was prepared by mixing 80 % Dulbecco’s Modified Eagle Medium 
(DMEM-Gibco), 20 % Fetal Bovine Serum (FBS-Biochrom) and gentamisin 
(50µg/ml). 
HAT medium was used as a post-fusion selective medium to eliminate unfused or 
self-fused myeloma cells. It was prepared by adding 40ml/L hypoxanthine 
aminopterin thymidine (50X HAT) to growing medium and stored at -20oC.  
HT medium was used as a rescue medium to overcome the effects of residual 
intracellular aminopterin. It was prepared by adding 20ml/L hypoxanthine thymidine 
(100X HT) to growing medium and stored at +4oC. 
Freezing medium was used to store F0 myeloma cells, hybrid cells and 
macrophages at -80oC. It was prepared by mixing 80 % Dulbecco’s Modified Eagle 
Medium (DMEM-Gibco), 20 % Fetal Bovine Serum (FBS-Biochrom) and 10 % 
DMSO (Dimethyl Sulphoxide). 
2.1.10 Cells and antigen 
Cell lines used in hybridoma study are described in table 2.13. 
Table 2.13: Cell lines that were used in hybridoma production 
Cell Source 
Myeloma F0 ATCC CRL-1646 
Feeding Cell Macrophage (cells from 
peritoneum fluid) 
BALB/c mouse 
Spleen Cells B lymphocyte BALB/c mouse spleen 
Lymph Cells B lymphocyte BALB/c mouse  lymph node 
Recombinant katanin p60 antigen was produced by cloning and protein expression 
assays in this study.  
2.1.11 Experimental animals 
The 6-8 week old female Balb/c mice were used for immunization. 
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2.2 Methods 
2.2.1 Cloning studies 
2.2.1.1 Primer design 
In order to clone desired nucleotide sequence of recombinant katanin p60 subunit 
from Rattus norvegicus katanin p60 full nucleotide sequence that was inserted pCR 
2.1-TOPO T/A cloning vector to pET-30a expression vector, two primers with 
appropriate flanking restriction sites were designed since restriction sites in cloning 
vector are not suitable. During primer design, melting temperatures of primers were 
selected as close as possible to each other to apply the optimum annealing 
temperature. GC content of primers was selected fewer than 50 % and hairpin and 
self dimer formation were checked by IDT Scitools oligo analyzer (Url-6). 
Synthesized primers with their properties are given below: 
Table 2.14: Recombinant katanin p60 sequence specific primers 
Primer Sequence Length Tm  GC 
content 
DF AAAGAATTCTGGTCTTTGCCGGTAC 25 57,5oC 44.0 % 
DR ATAAAAGCTTTAATTTGTTCTTTTCCTCTCTGC 33 56,7oC 30.3 % 
2.2.1.2 PCR 
Polymerase chain reaction is an easy technique that is used to amplify specific 
regions of a DNA strand quickly. Therefore, millions of copies of a specific DNA 
can be produced by using this technique that is based on enzymatic replication in 
vitro. Small oligonucleotides called primers are duplicates of nucleotide sequences 
on either side of the fragment DNA of interest. These primers provide a binding site 
on the template DNA for DNA polymerases. 
In a cycle of PCR, there are three basic steps in PCR. First, the target genetic 
material must be denatured-that is, the strands of its helix must be unwound and 
separated-by heating to 90-96°C. The second step is hybridization or annealing, in 
which the primers bind to their complementary bases on the now single-stranded 
DNA at an annealing temperature that is based on primers. The third is DNA 
synthesis by polymerase that is isolated from thermophilic bacteria at extension 
temperature that is based on used DNA polymerase. Starting from the primer, the 
polymerase reads the template strand and matches it with complementary nucleotides 
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very quickly. The result is two new helixes in place of the first, each composed of 
one of the original strands plus its newly assembled complementary strand. 
In order to amplify desired katanin p60 DNA part from the full katanin p60 DNA 
located in pCR 2.1- TOPO vector, following PCR reaction and PCR program were 
applied. 
Table 2.15: PCR reaction set up for cloning recombinant katanin p60 
Content Volume 
Template PCR2.1 TOPO-p60 (385ng/µl) 1 µl 
DF primer (25 µM) 1 µl 
DR primer (25 µM) 1 µl 
10X Pfu Buffer  (+ MgSO4) 5 µl 
dNTP (2mM) 5 µl 
Pfu DNA polymerase (2.5u/µl) 0.5 µl 
MQdH2O 36.5 µl 
Total reaction: 50 µl 
  
Table 2.16: PCR program for cloning recombinant katanin p60 
 Temperature Time 
Initial denaturation 95 oC 2 min 
Denaturation 95 oC 30 sec 
Annealing 56 oC 30 sec 
Extension 72 oC 30 sec 
Final extension 72 oC 8 min 
2.2.1.3 Agarose gel electrophoresis 
Agarose gel electrophoresis is the most common procedure that is used to separate 
DNA fragments by their sizes and visualize them. DNA is negatively charged at 
neutral pH due to its phosphate backbone; hence it migrates to the positive pole in an 
electric field. In agarose gel electrophoresis, the DNA is forced to move through a 
sieve of molecular proportions that is made of agarose. The end result is that large 
pieces of DNA move slower than small pieces of DNA. In this project, 2 % low 
melting agarose gels were used to estimate the size of DNA molecules following 
PCR reaction and restriction enzyme digestion. 
To prepare 2 % agarose gel, 1 gram (g) of low melting agarose: 
• Agarose was dissolved in 50 ml (small gel) 1X TBE (Tris/Borate/EDTA) buffer. 
• The agarose was solubilized in a microwave oven until the agarose was 
completely dissolved.  
35 cycles 
each 
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• Gel was cooled to ≤ 45ºC and ethidium bromide was added to a final 
concentration of 0.5 µg/ ml and mixed through gentle swirling. 
• The agarose gel was then poured into a horizontal gel tray, and a comb for 
forming the sample slots was placed into the gel. 
• The gel was solidified for about 30 min. and then placed into an electrophoresis 
tank, where the gel was covered by 1X TBE buffer used to make the gel. 
The DNA was mixed with 6X loading dye in the proportion of 6:1 and the sample 
was placed into a well on the agarose gel. For the fragment size control, a 
MassRuler™ DNA Ladder, Mix (80bp-10kb) was used. Electrophoretic separation 
was achieved by constant current at 120 mV for 30 minutes. 
DNA within agarose gels were visualized under UV light by staining ethidium 
bromide. The gel was placed onto an UV illuminator that emits UV light at 302 nm 
and photographed with a camera connected to a computer. Image files were saved 
with UVIPhotoMW Version 99.05 for Windows 95 & 98, UVItec Ltd. and 
subsequently analyzed. The size of the DNA was determined by comparing their 
mobility with the fragments of the DNA ladder. 
2.2.1.4 DNA cleanup 
In order to purify double-stranded PCR products (100 bp – 10 kb) and also to 
cleanup the restriction reaction products, QIAquick PCR purification kit was used. It 
is important to recover DNA and remove contaminants after PCR reactions and 
restriction reactions in cloning process. The principle of this purification is as 
followed: DNA adsorbs to the silica membrane in the presence of high 
concentrations of salt while contaminants pass through the column. Then, impurities 
are efficiently washed away, and the pure DNA is eluted with Tris buffer or water. 
The protocol is given below: 
• 5 volumes of Buffer PB to 1 volume of the PCR sample was added and mixed. 
• A QIAquick spin column was placed in a provided 2 ml collection tube in a 
suitable rack. 
• To bind DNA, the sample was applied to the QIAquick column and centrifuged 
for 1 min at 13.000 rpm. 
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• The flow-through was discarded and the QIAquick column was placed back into 
the same collection tube. 
• To wash, 0.75 ml Buffer PE was added to the QIAquick column and centrifuged 
for 1 min at 13.000 rpm. 
• The flow-through was discarded and the QIAquick column was centrifuged for 
an additional 1 min at 13.000 rpm. 
• The QIAquick column was placed into a clean 1.5 ml microcentrifuge tube. 
• To elute DNA, 50 µl Buffer EB (10 mM Tris·Cl, pH 8.5) was added to the center 
of the QIAquick membrane and the column was centrifuged for 1 min at 13.000 
rpm.  
2.2.1.5 Determination of DNA concentration  
To determine recovery, purity and concentration of nucleic acids, spectrophotometric 
analysis was used. The ratio of absorptions at 260nm vs 280nm is commonly used to 
assess the purity of DNA with respect to protein contamination, since protein (in 
particular, the aromatic amino acids) tends to absorb at 280 nm. According to the 
literature, the ratio of absorbance (A260/A280) of a pure DNA solution is between 1.8 
to 2.0. As protein contamination increases, the ratio decreases.  
In order to determine the DNA concentration, DNA solution was diluted 1:200 in 
distilled water and transferred to a quartz cuvette. The absorption was at wavelength 
of 260 nm. An optical density (OD) of 260 nm of 1.0 equivalent to 50 ng/ µl DNA. 
Following formula was used to calculate the concentration (C): 
C = OD 260nm x dilution factor x equivalent = x ng/ µl                                        (2.1)     
In order to check results of spectrophotometric analysis, purified DNA was also run 
on the 2 % agarose gel before ligation. 
2.2.1.6 DNA cleavage by restriction endonucleases 
A restriction enzyme also called restriction endonuclease is an enzyme that cuts 
double-stranded or single stranded DNA at specific recognition nucleotide sequences 
known as restriction sites that are palindromic in a length of 4 to 8 bases. Such 
enzymes, found in bacteria and archaea, are thought to have evolved to provide a 
defense mechanism against invading viruses. To cut the DNA, a restriction enzyme 
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makes two incisions, once through each sugar-phosphate backbone (i.e. each strand) 
of the DNA double helix. The purified restriction endonucleases are commercially 
available, and are used to generate DNA fragments for cloning experiments. 
Restriction enzymes used in this study were EcoRI and HindIII of which restriction 
sites were present in both expression vector and flanking region of PCR product 
(insert) but not found inside of  the insert. Plasmid vector was cut at 37oC for 4 hours 
and insert was cut over night at 37oC with 1X Tango Y buffer (supplied by the 
manufacturer). Restriction reaction was completed by inactivation at 80oC for 10 
minutes and then DNA was purified from restriction mixture by using QIAquick 
PCR purification kit. Restriction reaction mixtures are given in table 2.17. 
Table 2.17: Restriction reaction mixture 
Content Amount Volume 
Plasmid Vector (pET-30a) 
EcoRI 
HindIII 
10X Tango/Y Buffer 
5.72 µg 
10 units 
20 units 
1X 
10.5 µl 
1 µl 
2 µl 
1.5 µl 
Total Reaction Volume  15 µl 
Insert DNA 
EcoRI 
HindIII 
10X Tango/Y Buffer 
5.46 µg 
10 units 
20 units 
1X 
10.5 µl 
1 µl 
2 µl 
1.5 µl 
Total Reaction Volume  15 µl 
2.2.1.7 Ligation  
In order to ligate restricted expression vector (pET-30a) and the insert (katanin p60 
fragment), T4 ligase, that catalyzes the formation of phosphodiester bonds between 
neighboring 3´-hydroxyl- and 5´-phosphate ends in double-stranded DNA, was used. 
In addition, cohesive ligation type was performed and PEG 8000 was used to 
improve ligation reaction. To determine insert DNA concentration for ligation, 
following formula was used: 
Amount of insert = insert size/ vector size x 3 (molar ratio of insert/ vector) x amount 
of vector                                                                                                                   (2.2)                                    
Ligation was performed overnight at room temperature. After overnight incubation, 
T4 DNA ligase was inactivated by incubation for 10 min at 65°C. Ligation reaction 
mixture is shown in table 2.18 was used. 
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Table 2.18 Ligation reaction mixtures 
Content Amount Volume 
Plasmid vector (pET-30a) 300 ng 1 µl 
Insert DNA  360 ng 7 µl 
10 X T4 Buffer 1X 1,5 µl 
T4 Ligase 1 unit 1 µl 
PEG 8000 (%50v/w) 10 % 1,5 µl 
MQdH2O  3 µl 
Total Reaction Volume  15 µl 
2.2.1.8 Competent cell preparation- CaCl2 method 
Competent cells are bacterial cells that have been chemically treated to allow 
incorporation of foreign DNA/plasmids. They are critical to carry out transformation 
because normal E.coli cells do not have an ability to take foreign DNA from 
environment.  We homemade competent cells according to the following protocol: 
• E.coli – DH5α or E.coli-BL21 cells were taken from a glycerol stock culture by 
scraping with a tip and it was directly put in a falcon containing 5ml LB medium 
and incubated overnight at 37°C in an orbital shaker. 
• The following day, 100 ml LB medium was inoculated with 5 ml of overnight 
culture solution and was incubated at 37°C in an orbital shaker. Cell density was 
measured several times by a spectrophotometer at OD600. When the OD600 
reached to 0.6 the bacteria were transferred to 50 ml prechilled sterile 
ultracentrifuge tubes and incubated on ice for 10 min.  
• The cells were spun down at 1600 x g for 7 min. at 4ºC, the supernatant was 
discarded. 
• Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2 and centrifuged for 
5 min. at 1600 x g at 4ºC, the supernatant was discarded. 
• Each bacterial pellet was resuspended in 10 ml ice-cold CaCl2 and they were 
incubated on ice for 30 min. 
• Centrifugation was performed again at 1600 x g for 5 min. at 4ºC 
• Each pellet was resuspended completely in 2 ml of CaCl2. 
• The competent cells were distributed into prechilled sterile microfuge tubes each 
contains 50 µl and they were stored at – 80ºC. 
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For 50 ml CaCl2 solution following contents with mentioned concentrations and 
amounts in table 2.19 were used. 
Table 2.19: CaCl2 solution preparation 
Content Concentration Amount 
CaCl2.2H2O 
PIPES 
Glycerol 
dH2O 
60 mM 
10 mM 
15 % 
X 
0.442 g 
0.15 g 
7.5 ml (from 100 %) 
up to 50 ml 
2.2.1.9 Transformation of competent cells 
Transformation is the term used to describe the introduction of plasmid DNA into 
bacteria. As mentioned above, competent cells were used for transformation. 
Transformation can be performed by either an electrical or a chemical method. We 
used the chemical method which consists of a heat shock to introduce the DNA into 
the host as follows;  
• The competent cells were taken from –80oC and thawed on ice. 2 µl of purified 
plasmid DNA or 15 µl of ligation mixture was added to 20 µl of competent cells 
and the eppendorf tube containing the cells was incubated on ice for 30 minute 
(min.). 
• Then, heat shock was done by putting the cells in waterbath at 42o C for 45 
second (sec.) and they were then immediately incubated on ice for 2 min.  
• 80 µl of SOC medium was added to competent cells and the eppendorf tube was 
vigorously shaked at 37o C for 1 hour.  
• The cells were then spreaded onto LB plate containing the appropriate antibiotic 
(kanamycin). The plates were incubated at 37o C overnight. 
2.2.1.10 Colony PCR 
After transformation of ligated plasmids, colony PCR was performed to be sure of 
selecting right colonies which were carrying inserts. Colony PCR is essential because 
some colonies that gain antibiotic resistance can be empty. 
• 10 µl of sterile MQdH2O was put into PCR tubes for each colony that was taken 
from the replica plate by sterile tips and incubated at room temperature for 5 
minute to drop into water. 
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• Tubes which contain water and a piece of colony were incubated at 85oC for 5 
min to blow up cells and release plasmids. 
• Then, PCR mixture mentioned in table 2.20 was added into tubes. The PCR 
program was the same as given before in table 2.16. 
Table 2.20: Colony PCR reaction for recombinant katanin p60 
  
 
 
 
 
2.2.1.11 Overnight culture preparation 
After identification of the right colonies which contains the inserts by colony PCR, 
these colonies were taken into the 5 ml LB medium containing 5 µl suitable 
antibiotic (kanamycin) which was added in order to make selection media. Then, 
they were incubated overnight with vigorous shaking (200rpm) at 37 oC.  
2.2.1.12 Small scale plasmid DNA preparation 
Plasmid preparation was performed using QIAGEN, QIAPrep Spin Miniprep Kit for 
small-scale (mini) preparations, following instructions of the manufacturer. The 
principle of this purification is to release plasmid DNA from bacteria by alkaline 
lysis and to remove all the RNA in the lysate by RNase. Then, since the plasmid 
DNA has the ability to bind selectively to glass fiber fleece in a centrifuge tube in the 
presence of a chaotropic salt (guanidine HCl), DNA remains bound. After washing 
steps performed to remove contaminating bacterial components, low salt elution 
removes the DNA from the glass fiber fleece. 
The protocol of QIAPrep Spin Miniprep Kit, QIAGEN is as follows: 
• Overnight culture described before was prepared (see section 2.2.1.11). 
• The next day, 5 ml culture which was in 50 ml falcon was centrifugated for 3 
minutes at 6800 x g rpm. The supernatants were discarded. 
Content Volume 
Template + water 10 µl 
DF primer (25 µM) 0.5 µl 
DR primer (25 µM) 0.5 µl 
10X Taq Buffer 2.5 µl 
MgCl2 (25 mM) 1.5 µl 
dNTP mix (10 mM) 0.5 µl 
Taq  polymerase 0.25 µl 
MQdH2O 8.75 µl 
Total reaction: 25 µl 
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• The bacterial pellet was resuspended in 250 µl buffer P1 which contains RNAse 
A and the suspension was transferred into an eppendorf tube. 
• To lyse the cells, 250 µl P2  buffer was added (contains LyseBlue that leads to 
turn mixture to blue color  if the suspension is done efficiently), mixed by 
inverting the tube 4- 6 times and incubated at room temperature for up to 5 min. 
• Lysis was stopped by addition of 350 µl ice-cold N3 buffer. Tube was again 
inverted 4-6 times immediately and incubated on ice for up to 5 min. 
• The mixture was centrifuged for 10 min. at 13000 rpm and the supernatant was 
transferred to the QIAprep spin column by pipetting. Chromosomal DNA was 
precipitated with cellular debris during centrifugation and this supernatant 
contained the plasmid DNA. 
• Again centrifugation for 1 min. at 13000 rpm was performed. Plasmid DNA is 
bound to the glass fibers pre-packed in the filter tube. Supernatant was discarded 
from the collection tube. 
• To wash the cells, 750 µl of Buffer PE was added to the filter tube and 
centrifuged at 13000 rpm for 1 min. Supernatant from collection tube was 
discarded. This step was done twice. 
• Tube was further centrifuged at 13000 rpm for additional 1 min. without adding 
anything. 
• The QIAprep column was placed in a clean 1.5 ml microcentrifuge tube. To elute 
the DNA, 50 µl Buffer EB (10 mM Tris•Cl, pH 8.5) was added to the center of 
the the QIAprep column and the DNA solution was obtained by centrifugation for 
1 min. at 13000 rpm. 
2.2.1.13 DNA sequencing 
In order to confirm recombinant katanin p60 DNA was insert into pET-30a 
expression vector, sequencing was performed.  
PCR for sequencing: Sequencing PCR is special kind of PCR in which single strand 
of DNA is amplified. Each dNTP is labeled with different fluorescent tag; therefore, 
resultant DNA fragment is fluorescently labeled. Single strand of DNA is desired to 
be exploited since two strands apparently interfere the fluorescence of each other. 
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Thus, only one primer is used in Sequencing PCR. All ingredients are placed on ice 
and reaction is performed in dark in order to preserve fluorescence. 
The plasmids with inserts were verified by DNA sequencing using Big Dye 
Terminator v 3.1 Cycle Sequencing Kit (Applied Biosystems). The sequence reaction 
was prepared in a sterile PCR tube by adding the compounds shown below: 
Table 2.21: Sequence PCR set up  
Content Amount Volume 
Big dye reaction mix  
5X sequence mixture  
X 
X 
2 µl 
2 µl 
Template DNA 150 ng 1 µl 
T7 Primer (promoter/ terminator) 25 µM 0,5 µl 
dH2O  X up to10 µl 
The sequence reactions were performed using a thermal cycler with the following 
program mentioned in table 2.22.  
Table 2.22: Sequence PCR program 
 Temperature Time 
Initial denaturation 95 oC 5 min 
Denaturation 95 oC 10 sec 
Annealing 50 oC/55 oC 10 sec 
Extension 60 oC 4 min 
Final extension 60 oC 8 min 
PCR product purification for sequencing: Since PCR product was contaminated with 
polymerase, a subsequent purification was performed. The protocol is given below: 
• 10 µl PCR product was taken in to microfuge tube then 2µl of 3M NaAc and 50 
µl ice-cold 95% ethanol were added to tube. 
• Tubes were incubated on ice for 30 min. 
• Mixture was centrifuged at 14000 rpm for 30 min. Supernatant was discarded, 
and pellet was resuspended in ice-cold 70 % ethanol. The mixture was vortexed 
vigorously for 1 min.  
• Tubes were centrifuged at 14000 rpm for 30 min. Supernatant was discarded. 
• Tubes were incubated at 95°C for 5 min. with caps open (in order to evaporate 
ethanol) 
• 20 µl of formamide was added to DNA pellet and the mixture was vortexed 
vigorously for 1 min.  
40 cycles 
each 
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• Tubes were again incubated at 95 °C for 5 min. with caps closed. 
• Tubes were immediately put on ice and kept at 4 °C until analysis. 
2.2.1.14. Alignment of sequence results 
Nucleotide alignments were made with EMBOSS Pairwise Alignment Algorithms 
Tool and NCBI BLAST tool (available online respectively at these web addresses: 
www.ebi.ac.uk/Tools/emboss/align/index.html and www.ncbi.nlm.gov/BLAST) in 
order to compare the sequencing results with originally expected one. 
2.2.2 Protein expression studies 
Recombinant DNA technology is used in protein expression to clone a protein 
coding DNA (cDNA) into a plasmid vector and express the protein in a host cell. In 
this study, katanin p60 cDNA was cloned into pET-30a expression vector that is 
under the control of T7 promoter and BL21 (DE3)pLysS cell strain was used as  host 
in order to express katanin p60 protein. This cell strain is lysogenic for lambda-DE3 
which contains the T7 bacteriophage gene 1, encoding T7 polymerase under the 
control of IPTG inducible lacUV5 promoter.  In addition, the protein expression 
studies of katanin p60 include; determination by SDS-PAGE analysis, purification by 
metal affinity chromatography and confirmation by western blot method. 
2.2.2.1 Protein expression induction 
pET-30a vectors with cloned katanin p60 and pET-30a without any insert as control 
were transformed into BL21(DE3)pLysS competent cells,  they were spreaded on LB 
agar plate containing kanamycin and incubated overnight at 37oC. The next day, a 
single colony from each plate was taken into 10 ml LB media (with kanamycin) in 
falcon tube and left for overnight growth at vigorous shaking at 37oC. Next day, 2 ml 
of overnight culture was diluted with LB media and placed into 50 ml LB media. 
Culture was incubated with shaking at 37°C until the OD600 reaches a value between 
0.6 and 0.8. After cells were induced with 0.5 mM IPTG, they are grown for 8 hours 
with shaking at 37°C. While cells were growing, samples were taken periodically for 
further analysis.  
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2.2.2.2 Total cell protein analysis 
• At various times (0-8 hours) following induction, 1 ml cell culture for induction 
analysis was collected by centrifugation for 5 min. at 14000x g in a microfuge. 
• Supernatant was discarded. Pellet was mixed with 50 µl 2X SDS sample buffer 
for SDS-PAGE analysis explained below 
2.2.2.3 Soluble total cell protein analysis 
• At various times (0-8 hours) following induction, 1 ml cell culture for induction 
analysis was collected by centrifugation for 5 min. at 14000x g in a microfuge. 
• Supernatant was discarded. Cell pellet was completely resuspended in 1 ml of 
ice-cold 20 mM Tris-HCl pH 7.5. 
• Suspension was incubated overnight at -80 °C. 
• Next day, it was thawed on ice. 
• The entire lysate was centrifuged at 14000×g for 20 min. to separate the soluble 
and insoluble fractions. 
• The supernatant was concentrated with TCA (trichloracetic acid) method which is 
as  follows: 
 250 µl (1/4 volume) of 100% TCA (w/v) was added to 1 ml of supernatant 
and vortexed.  
 Sample was incubated on ice for 15 min..  
 Then, it was centrifuged at 14000 x g for 30 min. and the supernatant was 
removed.  
 Pellet was washed twice with 200 µl of acetone; the mixture was vortexed, 
centrifuged for 5 min. at 14000 x g and supernatant discarded. 
 Finally, pellet was allowed to air dry thoroughly by leaving the tube open on 
the bench top. 
2.2.2.4 SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) 
Almost all analytical electrophoresis of proteins are carried out in polyacrylamide 
gels under conditions that ensure dissociation of the proteins into their individual 
polypeptide subunits and that minimize aggregation. Most commonly, the strongly 
anionic detergent SDS is used in combination with a reducing agent and heat to 
dissociate the proteins before they are loaded onto the gel. The denatured 
polypeptides bind SDS that confers a negative charge to the polypeptide in 
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proportion to the molecular weight of the polypeptide independently of its sequence. 
Therefore, SDS-polyacrylamide complexes migrate through polyacrylamide gels in 
accordance with the size of the polypeptide in an electric field.  
The effective range of separation of SDS-poyacrylamide depends on the 
concentration of polyacrylamide with bisacrylamide that forms cross-linking to form 
pores through which the SDS-polypeptide complexes must pass (Sambrook and 
Russell, 2001). Therefore, SDS-polyacrylamide gel with 15 % acrylamide 
concentration which is suitable for separating 10-43 kDa proteins was prepared since 
molecular weight of expressed katanin p60 protein was expected to be around 16 
kDa. Since SDS-PAGE method has a discontinuous system, two gel layer system 
were used: a stacking gel and a separating gel. This method was performed in a 
vertical gel chamber. Preparations of gels were mentioned below: 
Table 2.23: 15 % separating gel solution (5ml) 
Contents Volume 
30 % acrylamide (with 2.7 % bisacrylamide) 2,5ml 
1,5M Tris pH:8.8 1,30ml 
10 % SDS 50µl 
10 % APS 50 µl 
TEMED 2 µl 
dH20 1,10ml 
Table 2.24: 5 % stacking gel solution (2ml) 
Contents Volume 
30 %acrylamide (with 2.7 % bisacrylamide) 330µl 
0,5M Tris pH:6.8 250 µl 
10 % SDS 20 µl 
10 % APS 20 µl 
TEMED 2 µl 
dH20 1,4ml 
The amounts mentioned above are sufficient to make 1 mini gel in a cassette from 
Bio-Rad Laboratories, the separating gel solution was applied into the gel cassette up 
to ± 6.5 cm, and, the last ± 2.5 cm of the cassette was filled with isopropanol, 
immediately. After the gel was polymerized for at least 20 min., the isopropanol was 
carefully removed by filter papers. The stacking gel solution was directly poured into 
the gel cassette, and the gel comb was placed to form the slots. The stacking gel was 
polymerized for at least 20 min., and used on the same day.  
The samples containing proteins were resuspended in 2X sample buffer (see section 
2.1.4.3). The samples were denaturated for 5 min. at 95ºC and taken on ice, then 5 µl 
of each sample was loaded on the SDS PAGE gel. As molecular weight marker, 10µl 
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SeeBlue Plus2 Prestained Protein Ladder (Invitrogen), containing 10 pre-stained 
protein bands (8 blue and 2 contrasting colors) in the range of 4-250 kDa, was loaded 
on the gel. 
Electrophoresis was carried out in Tris-glycine electrophoresis buffer (see section 
2.1.4.3). The electrophoresis was carried out at 120 V, 200 mA, 25W for 90 min.  
After electrophoresis was stopped, SDS-PAGE was stained in stain solution (see 
section 2.1.4.3) at 65oC for 15 min. with shaking at 50 rpm and then, it was destained 
in destain solution (see section 2.1.4.3) at 65oC for 30 min. with shaking at 50 rpm to 
visualize separated protein bands on the gel. 
2.2.2.5 Metal affinity purification of 6xHis tagged katanin p60 protein 
Immobilized-metal affinity chromatography (IMAC) was first used to purify proteins 
in 1975 (Porath et al., 1975) using the chelating ligand iminodiacetic acid (IDA). 
IDA was charged with metal ions such as Zn2+, Cu2+, or Ni2+, and then used to purify 
a variety of different proteins and peptides (Sulkowski, 1985). IDA has only 3 metal-
chelating sites and cannot tightly bind metal ions. Nowadays, Nitrilotriacetic acid 
(NTA) which is a tetradentate chelating adsorbent has wider use since it occupies 
four of the six ligand binding sites in the coordination sphere of the nickel ion, 
leaving two sites free to interact with the 6xHis tag (see figure 2.5). NTA binds metal 
ions far more stable than other available chelating resins (Hochuli, 1989) and retains 
the ions under a wide variety of conditions, especially under stringent wash 
conditions. The unique, patented NTA matrices can therefore bind 6xHis-tagged 
proteins more tightly than IDA matrices, allowing the purification of proteins from 
less than 1% of the total protein preparation to more than 95% homogeneity in just 
one step (Janknecht et al., 1991). 
 
Figure 2.5: Interaction between neighboring residues in the 6xHis tag and Ni-NTA  
                                   matrix (Qiagen handbook). 
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When lysate is mixed with Ni-NTA (nickel-nitriloacetic acid) agarose, nickel binds 
imidazole ring structure of histidine (Fig. 2.6). In elution step, highly concentrated 
imidazole in the elution buffer replaces histidine and histidine tagged peptide is 
eluted. 
 
Figure 2.6: Chemical structures of histidine and imidazole (Qiagen handbook). 
Purification of katanin p60 protein was made under native conditions and the 
protocol is given below: 
• 500 ml of IPTG induced bacterial culture was grown for 8 hours and centrifuged 
for 5 min. at 14000 x g. 
• The supernatant was discarded and the pellet was frozen overnight at -80oC. 
• Next day, it was thawed on ice, resuspended in 5 ml lysis buffer (see section 
      2.1.4.2) and centrifuged for 10 min. at 14000 x g. 
• 15 µl sample of lysate was taken for further SDS-PAGE analysis. 
• 500 µl of 50% Ni-NTA agarose was added to lysates and the mixture was gently 
mixed for an hour in eppendorf tubes at +4oC. 
• Then it was centrifuged at 4000 xg for 30 sec. to separate resin and supernatant. 
The supernatant (which is also called flow-through, since it passes through the 
resin) was transferred to fresh tubes for SDS-PAGE analysis. 
• The resin was washed twice with 2.5 ml of wash buffer (see section 2.1.3 
“Buffers”). It was centrifuged at 4000 xg for 30 sec after each wash step and the 
supernatant was taken for SDS-PAGE analysis. 
• Finally, the protein was eluted 4 times with 300 µl elution buffer (see section 
2.1.3 “Buffers”). Centrifugation at 4000 xg for 30 sec was done after each elution 
step and the supernatant. 
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2.2.2.6 Protein concentration determination 
Concentration of the purified katanin p60 protein was determined by Thermo 
scientific nanodrop 1000 spectrophotometer in DETAM, Istanbul University. Protein 
concentration was determined by loading a sample droplet (2 µl) onto the optical 
pedestal. The sample was then drawn into a column and measured at 280nm 
wavelength.  
2.2.2.7 Western blot 
Western blotting procedures involve the transfer of proteins that have been separated 
by gel electrophoresis onto a membrane, followed by immunological detection of 
these proteins. For immunological detection two layers of antibody are utilized. The 
primary antibody is directed against the target antigen. The secondary antibody is 
specific for the primary antibody and it is usually conjugated to an enzyme such as 
alkaline phosphatase (AP) or horseradish peroxidase (HRP), and an enzyme-
substrate reaction is part of the detection process. Antibody incubations are generally  
carried out in antibody buffer containing Tris buffered saline with Tween (TTBS) 
and a blocking reagent. Colorimetric AP systems use soluble 5-bromo-4-chloro-3- 
indolyl phosphate (BCIP) and nitroblue tetrazolium (NBT) as substrates to produce a 
stable reaction product (indigo dye and insoluble formazan) that will not fade. 
For western blotting of katanin p60 protein, the following protocol was applied: 
• SDS-PAGE was done. 15 % separating gel was prepared. 20 µg sample was 
loaded onto gel. 
• Electrophoresis was done until all of the dye (sample buffer) has left the gel. 
• Then, the current was shut down. 
• The PVDF membrane was prepared for Western blot, i.e. it was soaked in 
methanol and immediately placed into transfer buffer and kept there for 10 min. 
• The gel was placed in the “sandwich” chamber with 3 fiber pads and 2 filter 
papers and prepared PVDF membrane (2 fiber pads/ filter paper/ PVDF 
membrane/ gel/ filter paper/ fiber pad) all soaking in transfer buffer. 
• The trans-blot was run at 4° C (in the cold room) at 20 V for 2 hours. 
• The membrane was blocked with blocking solution (see table 2.25) on the shaker 
overnight at 4° C (in the cold room). Proteins in BSA containing solution block 
unoccupied sites on the membrane. 
56 
 
• Then, it was washed for 10 min. with TTBS solution. 
• After that, it was incubated with primary antibody in blocking buffer (see table 
2.26) at room temperature for 2 hours on the shaker. 
• After that, the membrane was washed twice for 10 min. with TTBS.  
• Then, the membrane was incubated with secondary antibody in blocking solution 
(see table2.27) for 1.5 hour at room temperature. 
• After that, it was washed twice for 10 min. with TTBS. 
• It was washed again for 10 min. with TBS in order to get rid of the detergent that 
was present in TTBS. 
• Finally, membrane was soaked into NBT/BCIP solution (200µl NBT/BCIP stock 
solution+ 10 ml NBT/BCIP buffer) and kept until the bands were seen. This last 
step was performed in the dark room. The reaction was stopped by adding water. 
• Membrane was dried at room temperature in the dark room. 
Table 2.25: Blocking Solution 
Content Concentration Amount 
BSA 3 % 900 mg 
TBS  30 ml 
Table 2.26: First antibody solution 
Content Concentration Amount 
Anti-His Penta (Mouse) 200µg/ml 5 µl 
BSA 3 % 300 mg 
TTBS  10 ml 
Table 2.27: Second antibody solution 
Content Concentration Amount 
Goat(anti-mouse) IgG AP conjugate 1:5000 2 µl 
Skim milk 3 % 300 mg 
TTBS  10 ml 
2.2.3 Monoclonal antibody production studies 
In order to produce monoclonal antibodies against expressed katanin p60 protein, 
hybridoma technology that is a process of hybridization of antibody secreting 
lymphocytes with tumor cells (myeloma) was used. Monoclonal antibody production 
studies include immunization of mice with katanin p60 antigen, immune response 
control, fusion and cell culture studies. 
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2.2.3.1 In vivo immunization procedure 
6-8 weeks old Balb/c mice species were used for immunization. Efficiency of 
immunization is based on type; structure and molecular weight of the antigen (see 
section 1.6). Adjuvants were used in conjugation with the antigen to alter the 
immune response of mice quantitatively and/or qualitatively. Therefore, 
immunization with soluble recombinant katanin p60 antigen (60µg /200 µl) was 
applied 3 times at days 0, 21 and 45 using complete Freund’s adjuvant (FCA- a 
mineral oil containing heat-killed mycobacterium) for the first immunization and 
incomplete Freund’s adjuvant (IFA- oil emulsion not containing bacteria) for the 
second immunization. 4 days before fusion as a last reminder, antigen in PBS pH 7.2 
(25µg/200µl) was injected intravenous, intraperitoneal, hand-foot pad of the mouse.  
For negative control mouse, PBS and adjuvant were mixed in 1:1 dilution and 
injected intraperitoneally. Mice injection methods were detailed in table 2.28. 
Table 2.28: Mice injection methods and dates 
Mouse Type Injection  
repeat 
Injection area Injection Contents Date 
 
Immunized by 
recombinant 
katanin p60 
(nrecp60) 
1th Intraperitoneal 60µg nrecp60/200µl 
FCA+PBS 
27.11.2008 
2nd Intraperitoneal 60µg nrecp60/200µl 
IFA+PBS 
18.12.2008 
3rd Intraperitoneal,  
intravenous, hand-foot 
pads 
 
25µg nrecp60/ 200µl PBS 
12.01.2009 
 
(-) Control 
1th Intraperitoneal 100µl FCA+100µl PBS 27.11.2008 
2nd Intraperitoneal 100µl IFA+100µl PBS 18.12.2008 
3rd Intraperitoneal 200µl PBS 12.01.2009 
After ten days from the second immunization, blood was taken from mice’s eyes 
(retro-orbital space) with hematocrit tube containing heparin as an anticoagulant to 
screen mice for antibody responses and detect the efficiency of antigen dose. The 
mouse giving the most effective antibody response was selected for the fusion by 
indirect ELISA test. In addition, blood was collected from the mouse’s heart to test 
activity of immune response in the day of fusion. Blood samples were centrifuged at 
10.000xg for 10 min. to gain sera in supernatant. 
2.2.3.2 Immune response control 
In order to detect animal’s immune response, Enzyme-linked immunosorbent assay 
(ELISA) method was used. Mice which were immunized by recombinant katanin 
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p60, their serum antibody titer was determined with indirect- ELISA method 
(Lipman et al., 2005). The protocol for indirect-ELISA method is given below: 
• 96 well ELISA plates were coated with 100 µl antigen solution. (Antigen amount 
for nrecp60; 1.2 µg/ml). Elisa plates were incubated overnight at 4oC. 
• Next day, plates were washed 3 times with PBS- Tween 20 (PBS-T) using Nunc-
ImmunoTM Wash8. 
• Plates were blocked with 1 %, 200 µl skim milk solution and incubated at 37oC 
for 1 hour. 
• Plates were washed 3 times with PBS-T using Nunc-ImmunoTM Wash8. 
• Hybridoma supernatants and mice sera were added separately in plates and 
incubated at either 37oC for 1 hour or overnight at 4oC. Supernatants of 
hybridomas were taken with micropipette and coated with an amount of 100 µl 
directly to the plate. Mice serums were diluted with PBS. 
• Plates were washed 3 times with PBS-T using Nunc-ImmunoTM Wash8. 
• Wells were coated with anti-mouse polyvalent immunoglobulins (IgG, IgA, IgM) 
or IgG (γ-chain specific) joined with alkaline phosphatase. Before this solution 
was coated on plates, it was diluted 1/2000 or 1/1000 with PBS and incubated at 
37oC for 1 hour. 
• Plates were washed 5 times with PBS-T. 
• After that, substrate buffer was added and incubated up to 1 hour in the dark at 
room temperature. Antibody level was detected at 405 nm by microplate 
spectrophotometer. 
2.2.3.3 Cell culture studies 
Transferring cells from -80oC to culture flasks: Cells which had been stored in -
80oC were thawed in 37oC water bath and taken in to 10 ml PBS buffer for 
centrifugation for 5 min. at 1400 rpm. Cell pellet was dissolved with DMEM 
medium and transferred to the culture flasks. 
Cell counting: Cell pellet was suspended with 20 ml PBS. Then 10 µl suspension 
was taken and put onto the hemacytometre, cells were counted as the number of cells 
per 25 square (1mm2). The formula of cell number calculation is given below: 
104 (constant number) X Amount of Counted Cell = Cell Number per ml  
Total cell number= Cell Number per ml X Total Volume of Cells (20ml)            (2.3) 
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Cell passage: Cells in the flasks or dishes were in growing medium. Growing 
medium was removed and 10-15 ml PBS was added. Cells that stuck on the culture 
dish were lifted via cell scraper. Suspended cells were put into the centrifuge tubes 
and spun at 900 rpm. After the centrifugation, supernatant was discarded and pellet 
was resuspended with PBS and again centrifuged.  
Cell freezing: After the cell passage, cells were taken into the centrifuge tubes and 
they were washed with PBS. When the washing step was finished, cell pellet was 
transferred to freezing tubes with freezing medium for future applications. Estimated 
cell number for per freezing tube was 2x106 cell/ml. 
2.2.3.4 Preparation for fusion 
Preparation of feeding cells: Feeder cells were prepared a day before the fusion. 
Unimmunized, normal mouse was used. After the mouse was anesthetized by ether, 
dislocation method was applied to the unimmunized mouse and then, it was 
disinfected in 70 % alcohol. Mouse was taken into laminar flow, was placed on the 
dissecting board in the dorsal position. Abdomen skin of mouse was separated from 
the underlying musculature to reveal peritoneum. 5 ml DMEM was injected to the 
peritoneum and after a few minutes, DMEM was taken back with feeding cell 
mixture from the peritoneum inner membrane. Feeding cell mixture was taken to the 
sterile tube and cell number was detected by cell counting. Desired cell concentration 
per well in cell culture plate is ~6000 cell/100µl. 
Obtaining spleen cells from immunized mouse: Among the mice, highest immune 
response giving was selected by indirect- ELISA test and was killed by dislocation 
method after it was anesthetized by ether. The mouse was sterilized with 70 % 
ethanol. Mouse was taken into laminar flow. The animal was laid on its backside. 
With the sterile scissors, left-sided skin incision was made, midway between the last 
rib and the hip joint. 1 to 2 cm incision was made in the peritoneal wall and spleen 
was pulled gently onto the exterior surface of the peritoneum. Any connective tissue 
under the skin was annihilated using the blunt end of the sterile forceps. The spleen 
was removed from the body. Spleen tissue was put into petri dishes containing 5 ml 
PBS buffer in order to purify it from the fatty tissues. Spleen tissues were crushed 
onto strainer with glass Baggett. After the spleen tissues were crushed, they were 
revealed and suspended with the help of pipette. Cells were washed 2 times with 20 
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ml PBS buffer at 1400 rpm for 5-10 min. Pellet was dissolved in 10 ml medium and 
cell number was determined by cell counting. Spleen cells are shown in figure 2.7. 
 
Figure 2.7: Image of spleen cells, adapted from Saatçılar (2008). 
Obtaining lymph nodes from immunized mouse: The highest immune response 
giving among the mice was selected by indirect- ELISA test and was killed by 
dislocation method after it was anesthetized by ether. The mouse was sterilized with 
70 % ethanol. Mouse was taken into laminar flow. Incision was started from genital 
region to lower (inferior) chin. Lymph nodes from chin and armpit, one pair on 
opened skin and groin, 4 nodes on intestine, 3 nodes on back, were collected (Fig. 
2.8). Removed lymph nodes were taken to the petri dish and mechanical force was 
applied to revealed lymph cells. After suspension, cells were counted. In this study, 
both lymph nodes and spleen tissue were collected at the same time. First, mouse 
was incised for getting the spleen tissue after that the lymph nodes were removed. 
 
Figure 2.8: Scheme reporting localization of the lymphatic system (Url-3). 
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Preparation of myeloma cells: Ten days before the fusion, F0 myeloma cells were 
started to be cultivated in normal medium (Fig 2.9). Beginning of cell reproduction 
studies, 20 µg/ml azoguanin was added to the medium for remove HGPRT (-) mutant 
cells. In the fusion day, myeloma cells were removed from the flasks by making 
passage and cells were washed 2 times with PBS buffer while centrifugation at 1400 
rpm for 5 min. Pellet was taken into 20 ml medium and cell number was determined 
by cell counting. Cells were held in 5 % CO2 incubator while preparing spleen cells 
and lymph nodes for fusion. 
 
Figure 2.9: Image of F0 myeloma cells, adapted from Saatçılar (2008). 
2.2.3.5 Fusion 
Myeloma/ spleen and myeloma/ lymph cells were combined in proportion to 1/2 and 
centrifuged at 1400 rpm for 5-10 min. After the centrifugation, supernatants were 
removed and pellets were taken. 1 ml (for spleen cells) and 500 µl (for lymph cells) 
polyethylene glycol (PEG) 4000 which was sterile and heated at 37oC was added to 
the precipitated cells drop by drop within 1 min. and mixed gently within another 1 
min. 4 ml (for spleen cells) and 2 ml (for lymph cells) DMEM was added within 1 
min. 20 ml (for spleen cells) and 10 ml (for lymph cells) DMEM was added within 2 
min. Finally, 20 ml (for spleen cells) and 10 ml (for lymph cells) DMEM that 
contains 15 % FBS was added within 2 min. Mixture was held an hour at 37oC in 5 
% CO2 incubator after that they were taken to the centrifuge at 800 rpm for 5 min. 
After the centrifugation, pellet was suspended with HAT culture medium and the 
formed mixture was dispersed to the cell culture plates which contained feeder cells 
that had been prepared one day before the fusion as a final amount 150µl/well. 
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2.2.3.6 Following culture after fusion 
 Six days and ten days after the fusion, 120µl/ well was removed from the cell 
culture plates and in place of removed medium, 120µl/ well HAT culture medium 
was poured. Fourteen days after the fusion, HT medium was poured with the same 
method. Growing medium was applied according to period of cells’ growth.  
In ten days period, cells had active, big and clear images and some of them could 
produce clones (Fig. 2.10). Cell culture wells were screened one by one by light 
microscope in order to determine hybrid cells. Then, hybrid cells which produced 
antibody against recombinant katanin p60 were selected by indirect ELISA method. 
 
Figure 2.10: Cell mixture after 10 days HAT medium (Saatçılar, 2008). 
2.2.3.7 Subcloning of hybrid cell (Limiting dilution) 
 Monoclonal antibodies are secreted by progeny of a single cell that can produce only 
a single antibody (assuming a nonsecretory fusion-partner line). Subcloning is 
required to ensure that the problems of polyspecificity are avoided and the risks of 
overgrowth by nonproducing cells are minimized. The procedure involves setting up 
cell cultures with graded dilutions of the cell suspension resulting in a mean of one 
cell per well (Liddell and Cryer, 1991).  
In this study, cells that were determined to give desired antibody were recloned for 
the purpose mentioned above. Recloned cells were frozen and stored. The recloning 
was repeated at least 3 times after which the final clone plate displayed positive 
antibody production. 
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2.2.3.8 Large scale production of hybridomas in vitro 
Hybrids were transferred to the different sized culture flasks to have high amount of 
antibody yield. For that reason, hybrids were cultivated in 25 cm2 and 75 cm2 culture 
flasks. After cell growing, supernatants containing desired antibody were collected in 
tubes. 
2.2.3.9 Subtyping of monoclonal antibodies 
In this study, ELISA test and IsoStrip mouse monoclonal antibody isotyping kit 
(Roche, cat. no: 1149027001) were used to determine the subtype of desired 
monoclonal antibodies. The kit procedure was performed in the Institute for Genetic 
Engineering and Biotechnology Division of The Scientific and Technological 
Research Council of Turkey- Marmara Research Center (TUBITAK-MAM). 
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3. RESULTS 
In order to produce monoclonal antibody against recombinant katanin p60, studies 
were performed in three steps which were cloning of selected katanin p60 sequence, 
expression of recombinant katanin p60 and producing monoclonal antibody against 
this protein. 
3.1 Cloning of Katanin p60 
Katanin p60 cDNA was present as cloned into pCR2.1- TOPO (Invitrogen) vector. 
Primers with flanking regions containing appropriate restriction enzyme sites were 
designed to specifically amplify selected a region (219 bp) of katanin p60 cDNA. 
Moreover, primers were designed according to Rattus norvecigus katanin p60 mRNA 
coding sequence data was taken from http://www.ncbi.nih.gov/ NM_001004217. 
PCR amplification of katanin p60 with designed primers successfully resulted in 238 
bp product (Fig. 3.1). 
 
Figure 3.1: 2% gel electrophoresis showing the result of PCR for katanin p60 (Lane 1: Fermentas   Mass 
Ruler Low Range DNA Marker, Lane 2 and 3: p60 PCR products) 
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Following PCR, DNA fragments were purified with QIAquick PCR purification kit 
and the concentration of DNA was checked on a 2 % agarose gel. The concentration 
was also checked by spectrophotometer at OD260. 
 
Figure 3.2: PCR product purification results. Lane 1- Fermentas Mass Ruler Low Range DNA 
Marker and lane 2- Katanin p60 cDNA. 
Purified katanin p60 DNA concentration was calculated as follows: 
C = OD 260nm x dilution factor x equivalent (50 ng/µl) = x ng/ µl                  (3.1) 
A260= 0.0529 
C= 0.0529x200x50= 529 ng/µl 
Amplified and purified katanin p60 cDNA was designed to be inserted into pET-30a 
expression vector. Therefore, cDNA and vector were restricted with HindIII and 
EcoRI enzymes, Fermentas (Fig. 3.3).  
 
 
Figure 3.3:  Multiple cloning site map for pET-30a expression vector, restriction sites are marked  
                        with arrows. 
Restricted DNA fragments were purified by QIAquick PCR purification kit. Before 
ligation, they were run on agarose gel in order to check restriction and the amount of 
DNAs were sufficient for ligation after purification (Fig. 3.4). 
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Figure 3.4: 2 % agarose gel electrophoresis showing restricted and purified insert (219bp) and vector  
                    (5422bp) DNAs. Lane1-Fermentas Mass Ruler Mix DNA Marker, Lane 2-pET30a vector, 
                    Lane 3-katanin p60. 
After that, ligation procedure was performed with Roche T4 DNA ligase overnight at 
room temperature and the ligation mixture was then transformed into competent E. 
coli DH5α cells. Transformed colonies were selected from selective antibiotic plates 
and colonies including katanin p60 cDNA were checked with colony PCR using 
forward and reverse primers of the insert to verify accuracy. Seven colonies were 
analyzed by PCR, and gel photo (Fig. 3.5) confirmed that all of them contained pET-
30a with p60 cDNA inserted. 
 
Figure 3.5: Colony PCR results for seven pET-30a-p60 transformed colonies 
After preliminary control of colonies including pET-30a with p60 cDNA, one of the 
colonies was selected and plasmid purification procedure was performed to collect 
plasmids. Collected plasmid DNA was subjected to sequence analysis to confirm 
inframe insertion and correct orientation of p60 cDNA. Obtained sequence was 
aligned with a theoretical one (Fig. 3.6). According to alignment results, no shift 
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mutation was observed. There was a C.T point mutation which does not change 
amino acid sequence since both CTA and TTA would end up encoding leucine 
amino acid. 
 
Figure 3.6: Alignment results of p60 in pET-30a expression vector. Expression vector part is    
underlined, restriction sites are in bold, the point mutation is circled, the rest part is   
p60 cDNA. 
3.2 Expression of Recombinant Katanin p60 
In order to express katanin p60, obtained construct of pET-30a- p60 was transformed 
into expression strain of E.coli BL21 (DE3)pLysS. A colony was picked from LB 
agar plate containing the selective antibiotic and dropped into LB medium. When the 
OD600 reached 0.7, IPTG to a final concentration of 0.5 Mm was added to bacterial 
culture growing in LB at room temperature to induce protein expression.  
In order to, determine the optimum expression time and detect the expressed 
recombinant katanin p60 protein, total cell protein analysis was performed by SDS-
PAGE method. For this purpose, bacterial samples were taken before IPTG induction 
(0 hour) and after IPTG induction at various times (from 2 to 10 hours). Protein 
samples were obtained from cell pellets and loaded into 15 % polyacrylamide gel 
(Fig. 3.7). 
 
 Figure 3.7: SDS- PAGE analysis of total protein samples. Bands of over-expressed recombinant  
                        protein p60 were showed by arrows, 
  Lane 1: pET-30a uninduced, 0 hour; 
  Lane 2: pET30a induced, 6 hour; 
  Lane 3: pET30a induced, 10 hour; 
  Lane 4: SeeBlue Plus2 Prestained Protein Ladder (Invitrogen); 
  Lane 5: pET30a-p60 uninduced, 0 hour; 
  Lane 6: pET30a-p60 induced, 2 hour; 
  Lane 7: pET30a-p60 induced, 4 hour; 
  Lane 8: pET30a-p60 induced, 6 hour; 
  Lane 9: pET30a-p60 induced, 8 hour; 
  Lane 10: pET30a-p60 induced, 10 hour. 
After induction with IPTG, a protein of ~ 20 kDa was detected in protein samples 
obtained from cell pellet. The expression of recombinant katanin p60 protein 
increased with time and was maximal at about 8 hour and began to decrease at the 
time 10 hour after IPTG induction. The amount of overexpressed protein p60 seemed 
very little at 2 hour but after four hours of induction, it becomes very distinguishable. 
No expressed protein was found in the control samples containing only pET-30a 
vector without katanin-p60 insert and in the uninduced samples (Fig 3.7). 
In order to check whether over-expressed katanin p60 is in the soluble fraction, cells’ 
pellets were lysed by freezing and thawing. Soluble and insoluble fractions were 
separated by centrifugation, soluble fraction was concentrated by TCA method and 
protein samples were again analyzed by SDS-PAGE method. No recombinant 
katanin p60 protein was observed in insoluble fraction (see Fig. 3.8). 
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Figure 3.8: SDS-PAGE analysis of 
                                                Lane 1: SeeBlue Plus2 Prestained Protein Ladder (Invitrogen)
                                                Lane 2: Soluble fraction of pET
                                                Lane 3: Soluble fraction of pET
                                                Lane 4: Soluble fraction of pET
                                                Lane 5: Soluble fraction of pET
                                                Lane 6: Insoluble fraction of pET
                                                Lane 7: Insoluble fraction of pET
                                                Lane 8: Insoluble fraction of pET
                                                Lane 9: Insoluble fraction of pET
According to SDS-PAGE analysis results, recombinant katanin p60 protein was 
observed in soluble fraction. Amoun
proportionally to the amount of total cell protein. Bacterial culture containing pET
30a without p60 insert (control samples) did not expose over
neither in soluble, nor in insoluble fractions.
3.2.1 Purification of recombinant katanin p60 under native conditions
Since studies of soluble and insoluble fractions showed that expressed katanin p60 
protein was in soluble state, it was decided to purify the His tagged protein under 
native conditions. All purification steps were given in detail in the Materials and 
Methods part. 
At each purification step, the samples were taken and were further 
PAGE method (see Fig 3.9). 
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 Figure 3.9: SDS-PAGE analysis of purified katanin p60 under native conditions (Purified protein in  
                     elution fractions showed by arrows), 
                     Lane 1: SeeBlue Plus2 Prestained Protein Ladder;  
                     Lane 2: lysate of bacterial culture (see Materials and Methods part for details); 
                     Lane 3: lysate flow-through; 
                     Lane 4: 1st wash fraction  
                     Lane 5: 2nd wash fraction; 
                     Lane 6: 1st elute 
                     Lane 7: 2nd elute; 
                     Lane 8: 3rd elute; 
                     Lane 9: used Ni-NTA agarose total protein; 
                     Lane 10: pET30a–p60 after 12 h growth total protein pET 30a – p60 after 8 h growth. 
Distinct protein bands were seen in elution fractions clearly and the protein amount 
decreased gradually in elution steps. In order to check whether the purified protein is 
the same as the overexpressed one, the control sample containing total protein 
fraction from bacterial cultures with pET-30a-p60 construct was applied to the SDS-
PAGE gel as well. In addition, the overexpressed katanin p60 protein band was 
observed in bacterial cell lysate sample and this band was missing in the flow- 
through sample since overexpressed katanin p60 bound to Ni-NTA agarose with its 
His-tags during purification process. In wash fractions, katanin p60 protein bands 
were not observed as expected. Some of used Ni-NTA agarose was applied to SDS-
PAGE gel as well, in order to determine the protein amount retained on resin. It was 
observed that protein on resin sample’ band is the thinnest of all elution samples’ 
bands that means most of the protein was eluted with elution buffer. 
Purified protein concentration was measured by nanodrop spectrophotometer at A280. 
It showed that the protein concentration (~3 mg/ml) was the same in first and second 
elution but concentration after third elution reached 1.4 mg/ml. 
 
64 kDa 
50 kDa 
 
36 kDa 
 
 
 
22 kDa 
 
16 kDa 
   1          2          3            4          5           6           7          8           9        10  
3.2.2 Western blot analysis 
In order to be sure that purified protein was really the His
Western blot analysis was performed. Samples of 
expression vector and with katanin p60 
(after 8 hours following IPTG induction) 
fraction were analyzed by western blotting. Total protein fraction and elution 
samples gave signals of His tagged protein of the expected size
control sample (Fig.3.10). 
Figure 3.10: Western blot analysis of total protein fraction and purified protein
                                        Lane 1: SeeBlue Plus2 Prestained Protein Ladder
                                        Lane 2: Purified protein (after first elution)
                                        Lane 3: Purified protein (after second elution)
                                        Lane 4: Purified protein (after third elution)
                                        Lane 5: Purified protein (after fourth elution)
                                        Lane 6: Total protein fraction of pET
                                        control); 
                                        Lane 7: Total protein fraction of pET
                                        control). 
3.3 Monoclonal Antibody Production
Balb/c female mice were immunized 
recombinant katanin p60 protein to produce mo
Materials and Method section). Even though, the immunization procedure was began 
with three mice and a negative control, two 
Therefore, the studies were continued with an immunized mouse and a negative 
control mouse. 
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3.3.1 Immune response control
Ten days after second immunization with recombinant katanin
immune response of the immunized mouse and the control mouse were co
For this purpose, the titer of antibody in mice sera was determined using indir
ELISA method (Fig. 3.11)
Figure 3.11: Mice’s serums were
                            immune response.
In order to measure antibody response, blood serum was collected from retro
space of mice. The blood was taken by hematocrit tubes containin
anticoagulant and poured into microfuge tubes. Tubes were centrifuged 
for 10 minutes to remove the blood cells. The plasma samples were tested by 
indirect- ELISA test system. Plasma from an unimmunized mouse in PBS was used 
as a negative control. Immunized mouse was seen giving high antibody titer against 
katanin p60 antigen even at 1/2000 dilution of the serum so it was taken to fusion 
studies. 
3.3.2 Optimization of antigen usage with ELISA Method
In fusion studies, high amount of 
antibody activity. Since expression processes of katanin p60 protein take long time
and are not economical, optimization of antigen usage must be determined. For 
determining the optimum antigen usage, ELISA plates were coated with various 
amount of katanin p60 antigen and by using active mouse plasma in different 
dilutions, optimum amount was determined for ELISA tests. 120 ng was found as the 
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most suitable antigen amount for antigen usage for ELISA tests. The result was 
shown in the Figure 3.12. 
 
Figure 3.12: Immunized mouse’s serum was tested for detecting optimum antigen usage for   
                          experiments. ELISA plate was coated with 15 ng, 30 ng, 60 ng, 120 ng and 240 ng  
                             amount of katanin p60. 
ELISA test mentioned above was carried out by anti-mouse alkaline phosphatase 
conjugated polyvalent immunoglobulins (IgA, IgM, IgG) as a secondary antibody 
and the results were obtained after 30 minutes incubation with substrate buffer. 
The similar test was performed with anti-mouse alkaline phosphatase conjugated IgG 
antibody in mouse’s serum to observe IgG antibody level in fusion day. In addition, 
polyclonal antibody response against katanin p60 (nrecp60) protein that was 
expressed in this study and another katanin p60 (rec p60) protein that was expressed 
from a different region of full katanin p60 in the previous study were tested.  Cross 
reactivity of the mouse’ serum with other proteins such as tubulin, skimmed milk 
powder and BSA was also checked. The IgG antibody titer was found high and the 
cross reactivity was low according the results (Fig. 3.13). 
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Figure 3.13: IgG response of immunized mouse against several amount of katanin p60 in different  
                        serum dilutions. nrecp60: new recombinant katanin p60 protein, recp60: recombinant    
                        katanin p60, BSA: Bovine serum albumin. 
3.3.3 Results of fusion studies 
In this study, fusion was performed once. Following the fusion, on day 4 the first 
colonies started to appear and at around day 10 the number of hybridoma cells 
increased. The culture medium was replaced with fresh medium. The hybridomas 
were refed every 3-7 days according to their growth and on day 13 the number of 
hybridomas were 57 on eight 96-well plates. After that, number of observed 
hybridomas was increased day by day. The hybridoma supernatants were tested in 
ELISA. Most of the hybridomas did not prove to be stable cell line. After several in 
vitro passages, replication of the cells ceased and the hybridomas were lost. 
Moreover, antibody activities of antibody producer hybrid cells decreased day by day 
probably one of the reason can be chromosome loss in the hybrid line secreting 
antibodies. The fusion results were detailed in Table 3.1. 
Table 3.1: The detailed fusion results of immunized mouse with katanin p60 
 
Number of Cell  
Spleen Fusion  
40 x 106  
Lymph Node Fusion  
16x106  
Number of F0 Myeloma Cell  80x 106  32x 106  
Total Number of Studied Well  768 288 
Total Number of Hybrid Cell 295 1 
Number of Antibody Producer Hybrid Cell 25   0 
Antibody Producer Hybrid Cells in Maintained 
Manner 
3 (2H3, 4F2, 
7B10) 
0 
Specific Antibody Producer Hybrid Cell Against 
Katanin p60 
1 (2H3) 0 
76 
 
According to given information above, three hybrid cells mantained producing active 
antibody according to ELISA test. Antibody activity of these cells was maintained 
even after passages to six well, twelve well cell culture kostars and 25cm2 cell 
culture flasks. Therefore, 2H3, 4F2 and 7B10 hybrid cell supernatants were tested for 
cross reaction test with other antigens and proteins to identify the antibodies’ 
specificity. For this purpose, tubulin, skimmed milk powder, BSA and E.Coli BL21 
strain with pET-30a empty vector cell lysate were used as different proteins in cross 
reaction test. The aim of using bacterial lysate was to detect whether an activity is 
observed against a bacterial protein that comes in purified katanin p60. Antibody 
activities for katanin p60 (nrecp60) protein and another katanin p60 (rec p60) protein 
were also tested. 2H3 showed high specificity against nrecp60, at the same time it 
did not show any cross reaction with other proteins (Table 3.2). 
Table 3.2: Comparision of the reactivity (OD405) of the monoclonal antibodies (2H3, 4F2, 7B10) with      
different proteins. nrecp60: new recombinant katanin p60 protein, recp60: recombinant 
katanin p60 protein,     BL21-pET30a: E.Coli BL21 strain with empty pET30a vector 
lysate, BSA: Bovine serum albumin 
 
Hybrid 
Cells 
Proteins 
nrecp60 recp60 Tubulin BL21-pET30a Skimmed Milk 
Powder 
BSA 
2H3 1.271 2.198 0.140 0.203 0.134 0.147 
*4F2 0.452 0.581 - 0.691 0.953 0.921 
7B10 > 4 3.989 > 4 > 4 > 4 0.101 
* Cross reactivity of 4F2 was tested with other proteins mentioned above accept tubulin because it 
showed cross   reactivity with BL21-pET30a, skimmed milk powder and BSA in previous test and thus 
it was ignored. 
In ELISA test mentioned above, skimmed milk was used for blocking. Since 7B10 
showed cross reactions against other proteins but not BSA, it was again tested by 
blocking with BSA in order to understand whether antibodies in 7B10 hybrid cell 
supernatant show cross reaction with only skimmed milk powder and have activity 
against katanin p60 protein. It was observed that 7B10 showed high cross reaction 
with only skimmed milk powder and had no activity against katanin p60. It was 
understood that the reason of observing of 7B10 as an antibody producer hybrid cell 
against katanin p60 protein was that it showed cross reactivity against only skimmed 
milk that was used for blocking in ELISA test. That means 7B10 hybrid cell gave 
false positive result (Table 3.3). 
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Table 3.3: Results of ELISA test blocking with BSA. nrecp60: new recombinant katanin p60 protein, 
recp60:   recombinant katanin p60 protein, BL21-pET30a: E.Coli BL21 strain with empty 
pET30a vector lysate, BSA: Bovine serum albumin 
 
 
Hybrid Cell 
Proteins 
nrecp60 recp60 Tubulin BL21-pET30a Skimmed Milk 
Powder 
BSA 
7B10 0.305 0.164 0.107 0.134 > 4 0.101 
In order to estimate monoclonal antibody subtype produced by 2H3 hybrid cells, 
activity against katanin p60 protein was compared with different secondary 
antibodies: anti-mouse polyvalent immunoglobulins (IgA, IgM, IgG) and anti-mouse 
IgG immunoglobulin conjugated with alkaline phosphatase (AP) in ELISA test. 
According to results showed in Figure 3.14, monoclonal antibody (2H3) subtype was 
not IgG subtype, but it could be either IgA or IgM subtypes. 
 
Figure 3.14: Determination of monoclonal antibody subtype (2H3). 
In order to determine the exact subtype of the monoclonal antibody, the supernatant 
of 2H3 hybrid clone was analyzed by IsoStrip mouse monoclonal antibody isotyping  
kit and the monoclonal antibody was found to be IgM subtype. 
2H3 hybrid clone producing antibody with the highest specifity was subcloned by 
limiting dilution. At each stage of growth, hybrid cells were frozen in freezing 
medium in microfuge tubes at -80oC.  
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4. DISCUSSION 
Katanin is one of the microtubule severing protein consisting of two subunits; 
catalytic p60 subunit and regulatory p80 subunit. The enzyme p60 subunit breaks the 
microtubule (Harman et al., 1998; Mcnally et al., 2000). Katanin p60 has important 
roles in mitotic spindle formation in mitotic cells (Vale, 1991; McNally et al.; Buster 
et al., 2002) and in axonal growth and differentiation in neurons (Ahmad et al., 1999; 
Karabay et al., 2004). In neurodegenerative diseases, it is suggested that the loss of 
protective tau (one of MAPs) from microtubules in the axons results in abnormal 
microtubule severing. Therefore, katanin may also have a central role in the 
degenerative response during neuropathies such as Alzheimer’s disease (Yu et al., 
2007). A better understanding of the severing proteins is necessary for developing 
new approaches for diminishing the extent of axonal degeneration in a variety of 
neurological diseases. In addition; katanin levels are higher at the tips of growing 
neuronal processes at some developmental stages (Yu et al., 2005) and thus katanin 
may also comprise a function in regeneration of neuronal injuries (Yu et al., 2007). 
However, the interacting proteins of katanin are still not actually defined. 
In order to monitor cellular katanin p60 and find out its interacting proteins, the 
techniques such as immunostaining and immunoprecipitation need for specific 
antibody against katanin p60 protein. In this study, a recombinant katanin p60 
protein was expressed and a specific monoclonal antibody was produced against this 
protein to further use in above mentioned techniques.  
4.1 Recombinant Katanin p60 Protein Expression 
In order to obtain recombinant katanin p60 protein, cloning experiments were 
performed initially. In this case, an amino acid sequence was selected from full 
katanin p60 protein considering the specificity, solubility and inclusion of antigenic 
determinants of the protein to produce efficient anti-katanin p60 monoclonal 
antibodies. Thus, we sought to manage the problems that were encountered in the 
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previously produced monoclonal antibodies in our lab, like inefficient 
immunostaining and western blot analysis. 
For specificity of katanin p60 protein, full amino acid (aa) sequence of the protein 
(except C-terminal AAA domain) was truncated by using NCBI protein BLAST tool 
(Url-4) until resulting with a protein region of 73 aa (amino acids 98-170) which 
does not give any alignment with other proteins.  Since a polyclonal antibody against 
katanin p60 peptide (amino acids 115-148) was produced and showed to efficiently 
recognize the katanin p60 protein in brain cells (Karabay et al., 2004), while 
choosing the protein region we thought to preserve the amino acid sequence of that 
previously produced antibody due to its antigenic region. In addition, the protein 
which is used for immunizing mice should be soluble to produce antibodies against 
this protein efficiently because B lymphocytes of mice can bind to soluble proteins 
for recognizing and then producing antibodies. The best conditions for expression of 
soluble another construct of katanin p60 were determined considering the factors that 
affect the protein solubility in a previous study in our lab. pET-30a expression vector 
and BL21 (DE3)pLysS host strain were used and high yield in expression and 
solubility were gain for this construct. Therefore, the same conditions were 
performed for our construct of katanin p60 in this study, expecting to gain soluble 
katanin p60 protein. The amino acid sequence of our katanin p60 protein was also 
analyzed since amino acid sequence determines protein characteristics, including 
solubility. The hydrophobic regions of our recombinant katanin p60 protein may lead 
to insolubility of the protein hence; they were excluded according to the previous 
study. Cystein residues that are responsible for disulfide bond formation in protein 
folding process were also checked because any possibility for wrong disulfide bond 
formation might result in insolubility (Baneyx, 1999). It was observed that our 
katanin p60 amino acid sequence contained neither considerable hydrophobic regions 
nor cystein residues that could give rise to formation of insoluble protein.  
In this study, pET-30a expression vector was used for cloning studies since the 
reasons mentioned above. After efficiently cloning of selected katanin p60 cDNA 
into pET-30a expression vector, no shift mutation was observed according to 
alignment results. However, a point mutation (C.T) was found. It resulted CTA 
instead of TTA DNA codes which would end up encoding leucine amino acid. Since 
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the mutation does not change the amino acid sequence, the activity of the expressed 
protein was maintained.  
pET30a-p60 construct was transformed to E.coli BL21 (DE3)pLysS strain and after 
cultivation, expression was induced with 0,5mM IPTG. The highest amount of 
katanin p60 was observed at the 8th hour of the growth. According to SDS-PAGE 
analysis of total protein fraction after expression studies, an overexpressed protein of 
about 20 kDa was observed in the samples containing pET30a-p60 constructs (Fig. 
3.12 in Results section). Molecular weight of subcloned katanin p60 should have 
been about 8 kDa (8346.42 Da). When His-tag was fused to it, its molecular weight 
became ~ 16 kDa (16.10481 Da). However, SDS-PAGE analysis (15 % separating 
gel) showed the overexpressed protein in higher weight (~ 20 kDa). A longer than 
expected protein might be produced since bacteria may no recognize the first stop 
codon and extend translation process further (Gu et al., 2001). Another reason might 
be the fact that SDS-PAGE shows approximate molecular weight of the protein, it 
might seem different depending on the concentration of the gel.  
After SDS-PAGE of total cell protein analysis, soluble and insoluble fractions of 
total cell protein were differentiated to determine whether overexpressed katanin p60 
is in the soluble fraction. It was observed that the overexpressed katanin p60 was in 
soluble fraction. 
Overexpressed katanin p60 was purified to further use in mice immunization. 
Purification under natural or denaturating conditions is possible using Ni-NTA resin. 
We chose purification under natural conditions since expressed protein is soluble, as 
it was shown by total soluble and insoluble fraction analysis. Moreover, such 
purification does not distort protein conformation which is important for 
immunization efficiency. The potential for unrelated, nontagged proteins to interact 
with the Ni-NTA resin is usually higher under native than under denaturing 
conditions. Nonspecific binding can be reduced by including a low concentration of 
imidazole (10–20 mM) in the lysis and wash buffers. Nonspecific binding is reflected 
in the larger number of proteins that appear in the first wash. In our case both wash 
fractions seemed to be clear (see Fig. 3.14) which shows that only His-tagged protein 
has bound to the resin and most of the unrelated proteins were in the flow-through 
fraction. According to manufacturer’s recommendations (Qiagen handbook, 2003), 
imidazole concentration in elution buffer should reach 250 mM. However, 
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considerable amount of protein was left bound to resin even after four elution steps. 
We used elution buffer with imidazole concentration reaching 1 M. SDS-PAGE 
analysis confirms that after three elution steps with 1 M imidazole elution buffer 
most of protein is eluted (see Fig. 3.14). In order to determine the concentration of 
purified protein in elution buffer, nanodrop spectrophotometer was used.  
4.2 Monoclonal Antibody Production 
In 1975, Köhler and Milstein introduced the first version of a method to make 
monoclonal antibodies. Precursors of the plasma cells were isolated and fused with 
immortal cells of the B-cell lineage such as myeloma cells, which previously had 
been selected to no longer secrete antibodies. The resultant hybridoma cells could be 
single- cell cloned and then expanded as individual clones, which secrete only one 
antibody type. All of these antibodies are identical, with specific and easily studied 
properties of antigen recognition, and are known as monoclonal antibodies. 
Nowadays, monoclonal antibodies (MAbs) become important reagents used in 
biomedical research, in diagnosis of diseases, and in treatment of such diseases as 
infections and cancer (Lipman et al., 2005). A wide range of commercially available 
monoclonal antibodies are also used as laboratory reagents for ELISA assays, 
immunoblotting, immunoprecipitation, immunofluorescence, immonucytochemistry 
and immunohistochemistry methods. However, mouse anti-katanin p60 monoclonal 
antibody is not commercially available. Thus, we aimed to produce this kind of 
antibody to further use in methods mentioned above. This attempt could be helpful 
for well understanding katanin p60 behavior in most commonly studied cells. 
MAb production was achieved by hybridoma technology. This process included the 
following successive working phases: the generation of antigen specific B cells via 
immunization of mice, the fusion of these cells with myeloma cells, the cloning and 
selection of the specific hybridoma clone by “limiting dilution” and the up- scaling 
of MAb production. While producing antibodies, critical aspects including mice 
strain selection, antigen properties, aseptic antigen processing, adjuvant selection, 
preparation of antigen adjuvant mixture, choice of immunization route and injection 
volume were considered. In this study Balb/c mice strain was preferred since 
myeloma cell lines have been derived originally from such animals and they are so 
compatible for the propagation of hybridoma cells in vivo. Young adult animals such 
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as 6-8 weeks old whose immune response is robust and not affected by previous 
immune challenges were used in order to increase yield of immunization with 
katanin p60 protein. Moreover, female mice were used because we observed that 
female mice were milder in social interactions than male mice that were aggressive 
and could hurt other animals in the cage. The properties of katanin p60 that was 
produced in this study as an antigen was mentioned section 4.1. Immunizations with 
katanin p60 antigen were applied by intraperitoneal and intravenous routes and 
repeated for several times. First immunization of the antigen was done with Freud’s 
complete adjuvant that is a potent adjuvant and has been used successfully decades to 
enhance the immune response quantitatively and/or qualitatively. However, second 
immunization was performed with Freund’ incomplete adjuvant to minimize side-
effects of complete adjuvant that are formation of granulomas, inflammation at the 
inoculation site and lesions (Rudbach et al., 1998). 
In order to produce MAb, antibody secreting B cells derived from immunized mice 
were immortalized by the fusion with a nonsecretory myeloma cell line. Since the 
infused normal B cells could not survive long in an in vitro culture, they derive 
immortality by fusion to a partner tumor cell line. In this study, ATCC CRL 1646, F0 
cell line of myeloma (commercially available) was used.  
In fusion studies, high amount of antigen would be used for detecting hybrid cell 
antibody activity. Since expression processes of katanin p60 protein take long time 
and are not economical, optimization of antigen usage required to determine. 120 ng 
was found as the most suitable katanin p60 protein amount for antigen usage for 
ELISA tests. However, 240 ng of the protein was used then in order to catch the 
antibody activity of hybrids in early stage of growth because they were growing 
rapidly and dying immediately. 
Only one fusion study was carried on with this myeloma cell line but the second 
fusion experiments are still continuing. After first fusion study, 25 hybrid cells 
producing antibody were detected. However, 22 of them lost their antibody 
producing activity day by day and probably one of the reasons could be chromosome 
loss in the hybrid line secreting antibodies. In addition, they died after passages to six 
well, twelve well cell culture costars and/or 25 cm2 cell culture flasks since they 
might not manage to passaging stress. Hybrid cells named 2H3, 4F2 and 7B10 
maintained their antibody producing activity and gave high activity in ELISA test all 
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time even after passages thus, their supernatants were decided to be tested for cross 
reactivity. For this purpose, tubulin, skimmed milk powder, BSA and E.Coli BL21 
strain with pET-30a empty vector cell lysate were used as different proteins in cross 
reaction test. Since polyclonal cross reactivity of the immunized mouse serum was 
not observed against skimmed milk and BSA, it was expected antibody producing 
hybrid cells were not expected to show the cross reactivity. However, 4F2 showed 
cross reactivity with BL21-pET 30a, BSA and skimmed milk powder thus it was 
ignored (in the first cross reactivity test tubulin was not used). On the other hand, 
7B10 gave cross reactivity in the same value with all other proteins except BSA. 
Therefore, we thought that this situation could be because of usage of skimmed milk 
powder for blocking protein in ELISA test. However, it was observed that 7B10 gave 
high activity with only skimmed milk powder and did not recognize katanin p60 
when the ELISA plate was blocked with BSA. Although cross reactivity of serum 
was not observed, the reason of cross reactivity of these cells might be that they were 
in spleen and not secreted to blood stream yet when the blood sample was taken. 
Another reason could be secretion of these cells to blood in insufficient amounts to 
give cross reactivity. 
One potentially specific hybrid named 2H3 was found against recombinant katanin 
p60 protein since it does not give any cross reaction with other proteins in ELISA 
test. In order to reduce antibody producing cell mass of 2H3 into one cell, limiting 
dilution method was used. Continued growth of this clone could result in a long-term 
dependable source of monoclonal antibodies. The produced antibodies were tested 
for immunoglobulin subtype determination by ELISA tests and mouse monoclonal 
isotyping kit system; the results showed that they were IgM subtype.  It is common 
to come across with this result. This is because antigen which enters the body does 
not stimulate T cells and macrophages; instead stimulates B cells directly. Moreover, 
antigen which chooses thymus in independent stimulation has a lot of same epitopes 
so that genetic modification of antigen is directed to IgM synthesis of antibody. 
However, this response can be mitigated by binging of antigen to carriers or by 
immunizing the animal with an adjuvant.  
In order to determine whether the produced monoclonal antibodies will recognize the 
wild type katanin p60 in cells, western blot and immunostaining techniques will be 
performed by using anti- mouse IgM immunoglobulins as secondary antibodies. 
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 However, the majority of monoclonal primary antibodies for use in 
immunocytochemistry (ICC) are of the IgG Isotype (IgG1, IgG2a, IgG2b, or IgG3). 
Most ICC detection systems contain a fluorescein conjugated secondary antibody 
that is directed against both the heavy and light chains of mouse IgG. On the other 
hand, there are a number of commercial monoclonal primary antibodies that are of 
the IgM isotype (heavy chain). Due to the pentameric structure of IgM, and its 
incomplete sequence conservation between the heavy chain regions of IgM and IgG 
isotypes, there are often difficulties obtaining optimal staining results when using an 
IgM isotype primary antibody with an anti - IgG secondary antibody. An IgG 
secondary antibody will recognize and cross-react with an IgM heavy chain. 
However, results are sub-optimal and prolonged incubations are often required. 
Therefore, a secondary antibody that is specific to IgM isotype is preferable. The use 
of a secondary mouse IgM heavy chain leads to improved staining characteristics and 
incubation times can be shortened due to the higher affinity of the reaction. However, 
binding of IgG monoclonal antibodies tend to be more specific than IgM type 
antibodies. Thus, false positive results due to IgM antibodies can be avoided by using 
IgG monoclonal antibodies as both primary and secondary antibodies in 
immunocytochemistry. In this case, IgG subtype monoclonal antibodies against 
katanin p60 could be produced by second fusion study. 
 
 
 
 
 
 
 
 
 
 
 
86 
 
 
 87 
 
5. CONCLUSION 
Katanin p60 is a severing protein whose functions are critical for both mitotic and 
postmitotic cells such as neurons. In order to monitor cellular katanin and to find out 
its interacting proteins, the techniques such as immunostaining, immunoprecipitation 
and western blot need for a specific antibody against katanin p60. In this study, we 
aimed to produce a specific monoclonal antibody against a recombinant katanin p60. 
To achieve our goal, an amino acid sequence was initially selected from full katanin 
p60 protein considering the specifity, solubility and inclusion of antigenic 
determinants. This katanin p60 subsequence was cloned into an expression vector 
(pET30a-p60) succesfully without any mutation on the aminoacid sequence. After 
induction, subcloned p60-katanin was expressed in soluble form, the greatest amount 
of the protein was observed after 8 hours of growth. Purification of recombinant 
katanin p60 protein was performed efficiently and Balb/c mice were immunized with 
this protein successfully. Monoclonal antibody production was achieved by 
hybridoma technology. After the fusion study, a monoclonal antibody (named 2H3) 
against recombinant katanin p60 was obtained. The antibody subtype was IgM 
according to ELISA tests and mouse monoclonal antibody isotyping kit system.  
In order to determine whether the produced monoclonal antibodies will recognize the 
wild type katanin p60 in cells, western blot and immunostaining techniques will be 
performed. 
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